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ABSTRACT 
Entamoeba histolytica and Giardia intestinalis are two of the most important and most 
widespread diarrhea-related parasitic protozoa in the world. Approximately 1200–1500 
cases of Giardia and 200–400 cases of Entamoeba are reported each year in Sweden, 
whereas the corresponding numbers are much higher in developing countries like 
Nicaragua. Traditionally, diagnosis of these parasites depends on microscopic 
detection of cysts or trophozoites, even though such methodology is neither sensitive 
nor species specific. Recently, more specific and sensitive molecular techniques have 
been introduced to identify these infections, but routine use of these tests in diagnostic 
laboratories is still limited.  
 
Amoebiasis, infection with E. histolytica, is a notifiable disease in Sweden. Despite 
that, diagnosis depends mainly on stool microscopy, which cannot distinguish between 
the invasive and pathogenic E. histolytica and the nonpathogenic E. dispar. We used a 
PCR technique to evaluate the proportions of these two species in patients who had 
amoebic infections and had initially been diagnosed by microscopy, and we found 
E. histolytica in less than 10% of those cases. Differentiation of E. histolytica and 
E. dispar is now a recommended analysis in Sweden, and this approach has greatly 
decreased the number of patients receiving unnecessary treatment. 
 
Giardia intestinalis consists of seven morphologically identical but genetically distinct 
genotypes or assemblages, which are designated A to G. Assemblages A and B can 
infect both humans and other mammals, whereas assemblages C to G are host specific. 
Sequence-based genotyping of Giardia isolates was applied to investigate the 
relationship between assemblages and symptoms, the zoonotic potential, sequence 
divergence, and transmission dynamics. Giardia samples obtained from humans and 
dogs living in the same area in Leόn, Nicaragua, as well as from humans and various 
animals in Sweden were analyzed using molecular methods. The investigation of the 
human samples indicated the following: assemblage B was the most common genotype 
in both countries, and this assemblage was largely polymorphic with ambiguous 
nucleotide positions in many sequences. In contrast, assemblage A isolates were 
genetically more homogeneous, and multilocus genotypes (MLGs) were easily 
determined for this assemblage. Most animals were infected with the host-specific 
assemblages C–G, but assemblages A and B were detected as well. A few animal and 
human isolates shared the same assemblage A MLGs, which suggests that zoonotic 
transmission of Giardia can occur in Sweden. Determination of MLGs may be a useful 
tool for source tracing in outbreak situations, although assignment of a specific MLG 
was hampered in many of the current isolates due to the large sequence polymorphism 
seen in assemblage B. The only correlation found between assemblages and symptoms 
concerned flatulence, which was noted to be significantly more common in young 
children infected with assemblage B.  
 
In conclusion, the combination of microscopy and molecular methods enabled us to 
differentiate between pathogenic and nonpathogenic Entamoeba species and thereby 
decrease the number of unnecessarily treated patients. Furthermore this 
methodological approach also gave us basic knowledge about Giardia genotypes in 
humans and animals, both in Nicaragua and Sweden, information that is useful for 
understanding the transmission and the clinical presentation of Giardia infection. 
. 
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1 INTRODUCTION 
 
The first time I had a chance to become familiar with human intestinal parasites was in 
Guinea Bissau, West Africa, in 1975. I was fascinated by the appearance of these 
organisms in the microscope, and I felt that this could be my future. Soon after that I 
got the opportunity to be trained in parasitology by the legendary ―Syster Birgit‖ at 
Roslagstull Hospital in Stockholm. In a way, things were easier at that time; a 
quadrinucleate cyst of the right size and the right morphology was Entamoeba 
histolytica, a Ziehl-Neelsen stained oocyst was Cryptosporidium parvum, and different 
Giardia genotypes were unknown to us. Later in life I had another opportunity, this 
time to learn how to use molecular methods to differentiate species and genotypes that 
were indistinguishable in the microscope. In this thesis, I have tried to combine my old 
knowledge in parasite morphology with the new world I am attempting to conquer. 
 
1.1 GENERAL BACKGROUND 
 
Diarrheal diseases 
More than 90% of the deaths from infectious diseases worldwide are caused by only a 
handful of diseases. The World Health Organization (WHO, 2004) ranks diarrheal 
disease as the second (after acute respiratory infections)
 
most common cause of 
morbidity and mortality in
 
children in the developing world. The etiological agents of 
diarrhea
 
include viruses, bacteria, and parasites,
 
and in this context the most important 
members of the latter group are Entamoeba histolytica, Giardia intestinalis, and 
Cryptosporidium
 
spp.
 
 
 
This thesis deals with two of the mentioned species: E. histolytica and G. intestinalis. 
Both these parasites have a low infectious dose, are spread through feces-contaminated 
food and water, have similar clinical presentations, and are commonly found in areas 
that lack sanitation and clean water. They have comparable, simple life cycles that 
comprise a resistant, infectious cyst form and a fragile, disease-causing trophozoite, 
which are also the diagnostic stages. Another common feature is what is called cryptic 
genetic variation, meaning that it is not possible to distinguish species or genotypes by 
morphological criteria (Clark, 2000). 
 2 
2 ENTAMOEBA HISTOLYTICA 
 
2.1 HISTORICAL NOTES 
 
In 1875, the Russian physician Friedrich Lösch described the first case of a dysenteric 
disease in man caused by an amoeba. His vivid description of the motility of the 
amoebas and the typical nucleus and ingested red blood cells reassures us that he was 
actually looking at trophozoites of what is now recognized as Entamoeba histolytica. 
Lösch originally chose a simple name for the organism, calling it Amoeba coli because 
it appeared in the colon (Lesh, 1975). In 1903, Fritz Schaudinn changed the name to 
E. histolytica due to the ability of the amoebas to cause tissue lysis (Clark, 1998). In the 
years that followed, the situation became confusing, since many species names were 
introduced for amoebas very similar to each other and to E. histolytica. In 1919, the 
famous English parasitologist Clifford Dobell published his now classical monograph 
―The Amoeba Living in Man‖ (Dobell, 1919). In this text, he reviewed all published 
articles that proposed various amoeba species and concluded that all Entamoeba that 
produced cysts with four nuclei were identical to E. histolytica. 
  
However, in 1925 the French parasitologist Emile Brumpt suggested the existence of 
another amoeba with quadrinucleate cysts, which he named Entamoeba dispar. Brumpt 
described this species as being morphologically identical to E. histolytica but not 
associated with disease in its host. He based his assumptions on epidemiological 
surveys that demonstrated high infection rates of quadrinucleate Entamoeba cysts in 
several European countries where invasive disease was almost unknown. He had also 
performed a number of experimental infections of kittens, which never led to disease. 
Despite that, when Brumpt presented his hypothesis at a meeting of the Royal Society 
of Tropical Medicine and Hygiene in London in 1928, he failed to convince his 
audience (Brumpt, 1928). First of all, there was evidence that amoebas from 
asymptomatic carriers were capable of causing disease in other individuals, as had been 
shown by Walker and Sellard in the Philippines in 1913 (Clark, 1998). Secondly, the 
suggestion by Brumpt did not suit the clinicians of the time. In the discussion that 
followed Brumpt's presentation, the prominent English parasitologist Wenyon made 
this statement (Brumpt, 1928): 
 
Professor Brumpt’s view if adopted would introduce clinical difficulties. 
On receiving a laboratory report that quadri-nucleated cysts of the 
histolytica type were present in the patient’s faeces the physician at 
once proceeded to inject emitine, but with Professor Brumpt’s theory 
put into practice … the clinician would first have to ask: Is this 
E. dispar or E. histolytica? 
 
At that time, the view among protozoologists was that a species always represented 
certain morphological criteria, which did not agree with the idea that two separate 
species could have identical morphology (Brumpt, 1928; Clark, 1998). Therefore, 
Brumpt and E. dispar were forgotten for almost 50 years. 
 
In 1978, Sargeaunt and Williams demonstrated that E. histolytica strains could be 
divided into two major groups—invasive and non-invasive—according to 
zymodemes revealed by isoenzyme electrophoresis performed on cultured parasites 
(Sargeaunt et al., 1978). Later, about 6,000 separate isolates of Entamoeba from all 
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over the world were investigated using the same technique (Sargeaunt, 1987), and all 
of them could be assigned to the two groups. The first of these was designated 
―pathogenic E. histolytica‖ and included isolates from patient with invasive disease 
and some cyst carriers; the second group, which was called ―non-pathogenic 
E. histolytica‖, consisted mainly of isolates from asymptomatic cyst carriers and 
contained no isolates from invasive cases.  
Biochemical, immunological, and genetic data were accumulated during the years 
that followed, and by 1993 enough evidence had been gathered to support the 
existence of two morphologically indistinguishable species (Strachan et al., 1988; 
Petri et al., 1990; Tannich et al., 1991). Consequently, the invasive and pathogenic 
parasite was redescribed retaining the name E. histolytica, and was set apart from the 
noninvasive E. dispar, in accordance with Brumpt's original hypothesis from 1925 
(Diamond and Clark, 1993). 
Four years later, in 1997, the WHO accepted this classification into two species and 
concluded that, in cases involving diagnosis based on light microscopy, the cysts 
should be reported as E. histolytica/E. dispar (WHO, 1997). However, this goal has 
not yet been reached, as indicated by a PubMed search conducted in June 2010, 
which revealed that, in 2009, 15 publications still reported the occurrence of 
E. histolytica based solely on microscopy, while 14 described correct finding of 
E. histolytica/E. dispar. 
 
2.2 THE PARASITE 
 
2.2.1 Taxonomy 
Entamoebas are anaerobic protozoan parasites that have traditionally been classified 
in the phylum Sarcodina, members of which are characterized by the presence of 
pseudopodia that are used for movement and uptake of food. According to more 
recent classification based on molecular trees, entamoebas belong to the phylum 
Amoebozoa and the class Archamoebea, and they are closely related to the slime 
molds (Cavalier-Smith, 2004). A number of species within the genus Entamoeba can 
infect humans, but only E. histolytica is of medical importance (WHO, 1997). 
 
2.2.2 Life cycle and morphology  
Entamoeba histolytica has a simple life cycle that comprises an infectious cyst form 
and an amoeboid trophozoite stage. The cysts measure 10–15 µm in diameter and 
contain one to four nuclei, depending on their level of maturation (Fig 1 A). The cysts 
have a thick wall made partly of chitin, which makes them resistant to both 
environmental stress and the gastric acid in the stomach of the host. The trophozoite is 
10–50 µm in diameter and contains a single nucleus. The nuclei of both stages have a 
small central karyosome and thin peripheral chromatin. The trophozoite moves in a 
characteristic way, which Lösch described in a very expressive manner when he first 
discovered the parasite in 1875 (Lesh, 1975). E. histolytica and E. dispar are similar 
with regard to cyst morphology, and the only morphological criteria that can be used to 
separate them is the erythrophagocytic trophozoites that are sometimes found in stool 
samples from patients with E. histolytica dysentery (Fig.1B). Humans and occasionally 
non-human primates (Rivera et al., 2010) are the only natural hosts of E. histolytica, 
thus the zoonotic importance of this parasite is limited. Infection occurs when cysts are 
transmitted by the fecal-oral route (ingestion of contaminated food or water) or through 
person-to-person contact. The infectious dose is considered to be low, around 10 cysts, 
even though the only experimental transmission of Entamoeba that has been done used 
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cysts of Entamoeba coli (Rendtorff, 1954a). Excystation occurs in the small intestine, 
and the trophozoites that are released migrate to the large intestine, where they 
reproduce by binary fission. Encystation takes place in the colon, thus completing the 
life cycle by excretion of cysts in the stool. In cases involving diarrhea, trophozoites 
can be excreted as well, but they can survive for only a short time outside the body of 
the host. Infections that remain luminal are usually asymptomatic, and clinical 
amoebiasis occurs only when the trophozoites disrupt the mucosal barrier and penetrate 
the colon wall, which causes ulcers that lead to amoebic dysentery. Much less 
frequently trophozoites are spread through the portal vein to the liver, and, very rarely, 
they even disseminate to other organs such as the lungs and brain.  
 
Figure 1. A: Trichrome stained cyst of E. histolytica with three visible nuclei and a chromatoid 
body. B: Trophozoite of E. histolytica with ingested erythrocytes (Photo: Birgit Lindberg, 
Roslagstull Hospital; courtesy of Teodor Capraru). 
 
 
2.3 CLINICAL PRESENTATION 
 
The term amoebiasis indicates infection with E. histolytica regardless of symptoms 
(WHO, 1997). The symptoms of amoebic colitis/dysentery usually emerge gradually 
over a period of one to several weeks, and they include abdominal pain and tenderness, 
painful sudden bowel evacuation (tenesmus), and bloody diarrhea. Less than 40% of 
the patients exhibit a fever, and some cases involve anorexia and weight loss (Stanley, 
2003). E. histolytica can also penetrate the colonic mucosa and spread through the 
bloodstream to the liver, where the trophozoites establish an amoebic liver abscess, 
which is the most common extraintestinal manifestation. Amoebic liver abscess (ALA) 
is more common in adult men than in adult women, and the typical patient is a 20–40-
year-old male with a 1–2-week history of fever and diffuse abdominal pain in the right 
upper quadrant (Stanley, 2003). 
 
It is also evident that not all humans infected with E. histolytica develop clinical 
disease. Indeed, studies conducted in countries where E. histolytica is endemic have 
estimated that, at most, only one in four E. histolytica infections progresses to disease 
(Blessmann et al., 2003; Haque et al., 2006; Ali et al., 2008a). 
 
 
 
 
A B 
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2.4 OTHER ENTAMOEBA SPECIES FOUND IN HUMAN STOOL 
SAMPLES 
 
Although E. histolytica is the only intestinal amoeba of clinical importance, it is 
essential to recognize both the morphological and the genetic variation of other 
Entamoeba species that infect humans, in order to make the correct microscopic 
identification and to create a foundation for molecular-based diagnostic methods 
(Santos et al., 2010). 
 
Entamoeba dispar is the most important morphological ―twin parasite‖ of 
E. histolytica. Although they are genetically distinct, these two species are each other's 
closest relatives in the genus Entamoeba. Besides being different with respect to 
pathogenicity, E. dispar parasites are much more difficult to establish in axenic culture 
(i.e., in the absence of other microorganisms) compared to E. histolytica trophozoites 
(Clark and Diamond, 2002), probably due to disparities related to the uptake of 
nutrients (Espinosa-Cantellano et al., 1998). Studies involving experimental infections 
have shown that a number of E. dispar strains can form liver abscess in certain animal 
species (Costa et al., 2006). Furthermore, a recent investigation in Mexico was the first 
to identify E. dispar DNA in human abscess material obtained from patients with 
bacterial abscesses and from ALA patients, in the latter group in combination with 
E. histolytica DNA (Ximenez et al., 2010). Nevertheless, E. dispar is (still) considered 
to be non-invasive and non-pathogenic in humans, although future studies may reveal a 
more complex picture.  
 
Entamoeba moshkovskii is a free-living amoeba, which forms quadrinucleate cysts that 
are morphologically indistinguishable from E. histolytica/E. dispar cysts. Even though 
sporadic human cases had been documented in the past (Clark and Diamond, 1991a), 
E. moshkovskii was previously believed to be an uncommon parasite in humans. 
However, studies carried out in several countries (Iran, India, Australia, Bangladesh, 
Tanzania, Tunisia, and Turkey) using the PCR (polymerase chain reaction) technique 
with specific primers for E. moshkovskii have detected this parasite in varying numbers 
of patients (Ali et al., 2003; Khairnar and Parija, 2007; Tanyuksel et al., 2007; Beck et 
al., 2008; Fotedar et al., 2008; Nazemalhosseini Mojarad et al., 2010). In one 
investigation (Fotedar et al., 2008), a correlation was found between E. moshkovskii 
and diarrhea, but the common assumption is that this species is not pathogenic. 
Interestingly, many of the reported human cases of E. moshkovskii have been co-
infected with E. histolytica or E. dispar, but the reason for this is unclear. The 
occurrence of E. moshkovskii in Sweden is not known, but a recent PCR based study of 
isolates containing quadrinucleate Entamoeba cysts from Swedish, Danish, and Dutch 
patients has suggested that this species is uncommon in our setting (Stensvold et al., 
2010b). Notwithstanding, it has been proposed that quadrinucleate cysts should be 
reported as E. histolytica/E. dispar/E. moshkovskii due the similar morphology of these 
three species (Pritt and Clark, 2008). 
 
Entamoeba coli is found all over the world and is probably the most prevalent of all the 
intestinal amoebas that occur in humans. Even though a Swedish publication linked this 
amoeba to diarrheal symptoms (Wahlgren, 1991), it is generally considered to be non-
pathogenic. Mature E. coli cysts have 8–16 nuclei and pose no diagnostic problems, but 
immature cysts with four nuclei can be confounded with E. histolytica/E. dispar cysts, 
especially considering that they overlap in size.  
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Entamoeba hartmanni was originally referred to as the ―small race‖ of E. histolytica, 
but it was redescribed as a distinct species in 1957 (Burrows, 1957). E. hartmanni is 
genetically quite distinct to E. histolytica/E. dispar, (Silberman et al., 1999), whereas it 
differs morphologically, mainly with respect to size. The disparity in size is usually 
clear (cysts <10 µm), and hence identification is not problematic. However, some 
isolates can harbor E. hartmanni cysts that are >10 µm in diameter, and if these are 
classified strictly according to the size criterion, they will be incorrectly identified as 
E. histolytica/E. dispar cysts.  
 
The two uninucleated amoebas Entamoeba polecki (found in pigs) and Entamoeba 
chattoni (detected in non-human primates), together with two other genetic variants, are 
now considered to be one species, E. polecki. These four variants of uninucleate 
amoebas have occasionally been observed in human samples and have been further 
investigated by molecular methods (Verweij et al., 2001; Verweij et al., 2003). Cysts of 
E. polecki might be mistaken for immature E. histolytica/E. dispar cysts, because they 
are equal in size (10–15 µm). E. polecki cysts should be suspected when only 
uninucleate amoeba cysts are seen, especially if the cysts are mature.  
 
Iodamoeba butschlii is another intestinal amoeba whose cysts and trophozoites have a 
characteristic nucleus that differs markedly from the nuclei of Entamoeba species. 
Despite that, Iodamoeba cysts are sometimes confused with immature cysts of 
E. histolytica/E. dispar. Notably, no sequences of Iodamoeba have yet been submitted 
to GenBank, probably due to the difficulties in maintaining this parasite in culture.  
 
2.5 LABORATORY DIAGNOSIS OF AMOEBIASIS 
 
2.5.1 Intestinal infection 
Sample collection and preservation 
The outcome of any diagnostic procedure depends largely on the methods used for 
sample collection and preservation, and different approaches are necessary for the two 
diagnostic stages of Entamoeba species, the cyst and the trophozoite. As shown in 
Figure 2, a formed stool is likely to contain cysts, whereas a watery or dysenteric stool 
will usually harbor trophozoites. Table 1 presents a comparison of the various fixatives 
used most often in diagnostic parasitology of intestinal protozoa in Sweden, and it is 
noteworthy that none of the suggested agents is optimal for all techniques. A fresh stool 
specimen obtained directly from the patient is seldom available but is essential if the 
aim is to detect mobile trophozoites. Fecal samples are often forwarded to the 
diagnostic laboratory by mail, thus it is necessary to use fixatives to preserve the 
trophozoites.  
 
Figure 2. Distribution of cysts and trophozoites in relation to stool consistency  
(http://www.dpd.cdc.gov/dpdx/html/DiagnosticProcedures.htm 
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Table 1. Comparison of different fixatives used to preserve stool parasites 
*Sodium acetate-acetic acid-formalin 
 
Microscopy 
For over 100 years, microscopy remained the only method for diagnosing intestinal 
Entamoeba infection, and, even though it cannot differentiate between E. histolytica 
and E. dispar, it is still the technique of choice in many parasitology laboratories 
worldwide. In light of our present knowledge, microscopy must be considered as a 
screening method for the E. histolytica/E. dispar complex and not as a technique to 
confirm the diagnosis of E. histolytica. 
 
Direct wet smear 
Direct microscopy of a wet smear requires a minimum of equipment (a slide, a cover 
slip, and a drop of saline), and it is probably the most widely used method for 
diagnosing intestinal protozoa throughout the world. It is fast and cheap, but its 
outcome depends entirely on the skills of the microscopist. A crude fecal sample 
contains numerous structures such as undigested food particles and human cells, 
which might be misinterpreted as protozoan cysts or trophozoites. Nonetheless, if 
interpreted correctly, microscopy is the simplest technique for diagnosing an invasive 
intestinal amoeba infection, because findings of Entamoeba trophozoites with 
ingested erythrocytes strongly indicate E. histolytica (Fig. 1). This is, however, rarely 
seen in a setting such as Sweden, where most of the Entamoeba patients harbor either 
only cysts or trophozoites without erythrocytes.  
 
Concentration technique 
In all Swedish parasitology laboratories, the standard method for detecting fecal 
parasites is a more or less modified form of the formal/ether concentration technique 
that was developed by Ritchie in 1948 (Ritchie, 1948). The method has been changed 
very little since that time, except that ether has been replaced by ethyl acetate (Young 
et al., 1979), and sodium acetate-acetic acid-formalin (SAF) may be used instead of 
formalin as the fixative (Yang and Scholten, 1977). With this technique, amoeba 
cysts are concentrated, whereas trophozoites are found only occasionally.  
 
 
Analytical method Unfixed 
sample 
Formalin
-fixed  
SAF*-
fixed 
Ethanol-fixed 
Direct microscopy of 
mobile trophozoites 
Yes (fresh 
stool required) 
No No No 
Formalin/Ethyl acetate 
(ether) concentration  
Yes Yes Yes No 
Permanent staining of 
trophozoites 
Yes (if fixed 
immediately) 
No Yes No 
ELISA for E. histolytica 
antigen detection 
Yes (less than 
48 h) 
No  No No 
Monoclonal antibody for 
E. histolytica/E. dispar 
Yes Yes Yes Yes  
PCR Yes (cysts) No No Yes (cysts and 
trophozoites) 
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Permanent staining techniques 
The most commonly used permanent staining techniques for cyst and trophozoite 
identification are hematoxylin-, trichrome- or chlorazol black dye-staining of fixed 
feces. American literature recommends that a permanent staining should be included in 
all parasite and ova examinations, whereas traditions in Europe have been more 
directed towards cyst identification after concentration techniques. However, the 
―rediscovery‖ of Dientamoeba fragilis, a diarrhea-related protozoan that lacks a cyst 
form, has prompted the use of permanent staining methods in Europe as well (van Gool 
et al., 2003; Schuster and Jackson, 2009). 
 
2.5.2 Extra-intestinal amoebiasis 
Few patients with extraintestinal amoebiasis have E. histolytica parasites in their 
stool samples (Fotedar et al., 2007a), thus other methods must be used for diagnosis 
in such cases. Antibody detection is the preferred laboratory technique in that context, 
and many different serology methods have been developed. The most widely used is 
enzyme-linked immunosorbent assay (ELISA), for which a recent study in 
Bangladesh indicated a sensitivity of 96% for ALA patients but only 46% for 
amoebic colitis patients (Haque et al., 2010).  
 
When using aspirated abscess material to diagnose E. histolytica infection, microscopy 
offers very low sensitivity, whereas both conventional and real-time PCR have proven 
to be valuable methods (Zaman et al., 2000; Khan et al., 2006; Othman et al., 2010). 
However, invasive techniques should be avoided due to the risk of bacterial 
superinfection or spillage of abscess contents, and they should be used only if 
absolutely necessary to confirm a diagnosis (Pritt and Clark, 2008). Haque and 
colleagues (2010) have observed that the combined results of real-time PCR performed 
on the non-invasive fluids urine and saliva reached a sensitivity of 97% for ALA and 
89% for amoebic colitis. This is a promising new approach for diagnosis of ALA, 
especially in endemic areas where serology is of limited value due to the difficulty of 
distinguishing between past and present infections. 
 
2.6 DIFFERENTIATION OF ENTAMOEBA SPECIES 
 
2.6.1 Zymodemes 
The zymodeme technique was the first procedure used to characterize different 
Entamoeba isolates and was long regarded as ―the gold standard‖ for this purpose. 
However, it requires the use of cultured amoeba trophozoites, and it is tedious and time 
consuming to perform. Furthermore, the sensitivity is low, because many samples that 
are positive by microscopy are culture negative. Although the zymodeme method is not 
currently used for routine species identification, it did play a major role in the early 
differentiation of E. histolytica and E. dispar (Sargeaunt et al., 1978). 
 
2.6.2 Antigen detection tests 
Specific detection of E. histolytica can be achieved by employing commercially 
available antigen detection kits, such as Entamoeba CELISA PATH and TechLab 
E. histolytica II, both of which use monoclonal antibodies against the same target: the 
Gal/GalNAc-specific lectin (adhesin molecule) of E. histolytica. Several studies carried 
out in Bangladesh, an area with high E. histolytica transmission, have shown that 
antigen detection has a high sensitivity, equal to PCR (Haque et al., 1997; Haque et al., 
1998), whereas investigations in non-endemic areas have demonstrated a poor 
sensitivity for antigen detection compared to PCR (Gonin and Trudel, 2003; Stark et 
al., 2008). This difference in test results between endemic and non-endemic areas is not 
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well understood, although it might reflect the fact that PCR is 100–1000 times more 
sensitive in detection of trophozoites than antigen tests (Mirelman et al., 1997; Stark et 
al., 2008). The conclusion so far is that the antigen testing, which is both rapid and 
technically simple, is appropriate in areas with high prevalence of E. histolytica but is 
not useful in settings where there are few cases of E. histolytica infection (Gonin and 
Trudel, 2003; Visser et al., 2006; Stark et al., 2008). 
 
2.6.3 Molecular methods  
DNA extraction  
The first Entamoeba PCR assays were performed on cultured trophozoites, thus DNA 
isolation was a minor challenge compared to the situation today, when DNA usually 
is extracted directly from stool samples. It is known that feces contain several PCR 
inhibitors (Abu Al-Soud and Radstrom, 2000), most of which should be removed by 
an optimal extraction procedure. Commercial spin columns (QIAamp
TM 
DNA mini 
kit or QIAamp
TM 
DNA stool mini kit) are among the most widely used devices for 
extraction of Entamoeba DNA directly from stool samples (Verweij et al., 2000; 
Gonin and Trudel, 2003). The extraction procedures often include initial cyst-
disrupting steps such as freezing and thawing, boiling, or bead-beater treatment. 
Nonetheless, manual extraction is time consuming and inconvenient when analyzing 
a large number of samples. Since molecular biology methods are becoming part of 
routine diagnostic techniques for detecting intestinal parasites, use of automatic 
extraction procedures is increasing (Bruijnesteijn van Coppenraet et al., 2009; 
Calderaro et al., 2010), although there is a lack of studies comparing manual and 
automatic extraction of stool parasites.  
 
PCR methods 
The earliest methods for differentiating E. histolytica and E. dispar included two 
single PCRs that target either the small subunit ribosomal RNA (ssrRNA) gene (Clark 
and Diamond, 1991b) or the gene encoding peroxiredoxin (a 30-kDa protein) 
(Tachibana et al., 1991). According to a very informative review published by 
Fotedar and colleagues (2007a), these techniques have been the most commonly used 
worldwide. Several more recent protocols for detection and differentiation of 
E. histolytica and E. dispar are now available, which include duplex PCR, multiplex 
PCR, nested PCR, and real-time PCR. In addition, a number of procedures for 
detecting E. moskhovskii have been described (Ali et al., 2003; Hamzah et al., 2006; 
Khairnar and Parija, 2007; Nazemalhosseini Mojarad et al., 2010). Entamoeba PCR 
assays target different loci, but the ssrRNA gene has been used most often for all 
Entamoeba species and, due to its multi-copy nature, the analytical sensitivity is 
usually high.  
 
2.7 MIXED INFECTIONS 
 
Sargeaunt and colleagues (Sargeaunt, 1987) observed very few mixed infections 
while performing isoenzyme electrophoresis on cultured trophozoites from thousands 
of Entamoeba isolates from many different settings. A plausible reason for this is 
that, in culture, one species may easily outgrow the other, as has been demonstrated 
in a model system using in vitro co-cultures and PCR detection (Pysova et al., 2009), 
in which E. dispar trophozoites outgrew E. histolytica within 48 hours in all assays. 
It remains to be determined whether the same is true for natural co-infections. PCR 
performed on DNA extracted directly from stool samples has indicated that mixed 
infections seem to occur mainly in endemic areas (Ramos et al., 2000; Nunez et al., 
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2001) and are rarely reported in European settings, although most E. histolytica or 
E. dispar infections that are diagnosed in Europe are acquired in endemic areas. 
 
2.8 GENETIC DIVERSITY OF E. HISTOLYTICA 
 
Investigations of genetic variation in coding and non-coding regions of different 
E. histolytica isolates might explain why some infections remain asymptomatic 
whereas others do not. In a study performed in Bangladesh (Ali et al., 2007), different 
genotypes were found in isolates from various patient groups (asymptomatic or 
suffering from colitis or ALA). Moreover, genotyping used in the investigation of a 
sexually transmitted outbreak of severe amoebiasis in Canada suggested that the 
patients involved were infected with a highly virulent genotype that differed from 
simultaneously examined strains that caused less severe infections (Salit et al., 2009). 
It has also been observed that paired isolates from stool samples and liver abscesses 
from the same patients differed genetically (Ali et al., 2008b), which implies that the 
patients in that study were either infected with mixed genotypes, or that some kind of 
DNA reorganization had taken place in the intestine or liver. 
 
2.9 EPIDEMIOLOGY 
 
The recognition of E. dispar as a separate non-pathogenic species meant that the 
results of all previous prevalence studies based on microscopy were not reliable. It 
was realized that E. dispar gave rise to about 90% of the 500 million new amoeba 
infections originally estimated to occur each year (Ackers and Mirelman, 2006). It 
also became evident that, at most, only one in four real E. histolytica infections 
progresses to disease (Ali et al., 2008a). All the same, amoebiasis does have a marked 
impact on global public health and has been estimated to cause around 40,000–
100,000 deaths annually, making it one of the leading causes of mortality from a 
parasitic disease (Stanley, 2003). 
 
Many prevalence studies have been performed since the introduction of PCR methods 
and antigen tests that can distinguish between E. histolytica and E. dispar. The most 
widespread occurrence of E. histolytica has been reported from certain countries in 
Latin America, Asia, and Africa, although local prevalence is highly variable (Ali et 
al., 2008a). However, even in countries such as South Africa and Mexico with a high 
prevalence of E. histolytica, E. dispar is responsible for a considerable portion of the 
infections (Ramos et al., 2005; Samie et al., 2006). 
 
Entamoeba in Sweden 
The first data on prevalence of Entamoeba infections in Sweden appeared in 1935 in 
Ruth Svensson’s groundbreaking thesis ―Studies on Human Intestinal Protozoa‖ 
(Svensson, 1935). The investigations she performed were based on microscopy of 
fresh unstained or stained stool preparations or culture (concentration techniques were 
not used in her thesis), and she found an E. histolytica prevalence of 2.3% in rural 
areas and 1.3% in the Stockholm area. It is impossible to know whether the parasites 
that she observed were E. histolytica or E. dispar, because only patients without 
intestinal symptoms were included in her research (and obviously no trophozoites 
with intracellular erythrocytes were detected). 
 
In two more recent studies conducted in Sweden (Svanteson et al., 1988; 
Svenungsson et al., 2000), less than 1% E. histolytica/E. dispar were detected in both 
control and diarrhea patients. In another Swedish investigation (Thoren et al., 1990), 
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both stool microscopy and serology were used to evaluate treatment of E. histolytica 
in asymptomatic homosexual men. According to the results, none of 42 cyst-positive 
patients had detectable antibodies, which suggests that the majority of infections were 
due to E. dispar. This might also have been the case in one of the few waterborne 
outbreaks of E. histolytica ever published. It occurred at a Swedish winter ski resort 
and comprised 1,480 persons who became infected with G. intestinalis and 106 with 
what was at the time believed to be E. histolytica (Andersson and De Jong, 1989). 
Unfortunately, no stool samples were saved from any of those patients, so we will 
probably never know which Entamoeba species was actually involved. 
 
In Sweden, infection with E. histolytica is a notifiable disease, but in most cases 
species differentiation is not performed in the laboratory where the initial microscopic 
diagnosis is made, and samples are infrequently sent for further analyses. 
Consequently, the data reported are inconclusive, and the true number of 
E. histolytica infections remains unknown. However, accumulated data from the 
section of Diagnostic Parasitology and Mycology (PDM) at the Swedish Institute for 
Infectious Disease Control (SMI) indicate that less than 10% of the microscopically 
diagnosed cases are due to E. histolytica (Paper I). 
 
2.10 TREATMENT 
 
The WHO recommends that E. histolytica/E. dispar should be differentiated when-
ever possible and that patients should not be treated based on microscopy findings 
alone. Yet, regardless of symptoms, all cases identified as E. histolytica should be 
treated due to the risk of invasive disease, whereas cases found to involve only 
E. dispar should not be treated. If a patient with E. dispar (or E. moshkowskii) has 
intestinal symptoms, a search should be made for other causes of disease. 
Asymptomatic E. histolytica infection should be treated with a luminal amoebicide 
(diloxanide furoate or paromomycin), and invasive intestinal or extra-intestinal 
amoebiasis should be handled by administering a tissue amoebicide (metronidazole) 
followed by luminal treatment (WHO, 1997). 
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3 GIARDIA INTESTINALIS 
 
3.1 DISCOVERY 
 
Almost 330 years ago, Antony van Leeuwenhoek examined his own diarrheal stool 
under a single-lens microscope and was the first to detect a human infection with an 
intestinal protozoan, describing the organisms he observed as ―oval animalcules a little 
bit bigger than blood cells moving around‖ (Dobell, 1920). In November 1681, van 
Leeuwenhoek sent a letter to the Royal Society in London to report his findings. In the 
book ―Leeuwenhoek and His Little Animals,‖ Dobell concluded that van 
Leeuwenhoek’s description corresponded well with the vegetative (trophozoite) stage 
of Giardia (Dobell, 1932). But the question is, using a microscope of the time, was it 
really possible to distinguish all the details that were recounted, such as the ―small 
paws‖ that the organism used to move around with? The answer is yes. The 
observations were recreated by the British scientist Brian Ford, who used the same kind 
of single-lens microscope as van Leeuwenhoek and was able to clearly view the 
Giardia trophozoites with surprisingly good resolution (Fig. 3A-C) (Ford, 2005). 
 
  A  B C 
 
 
 
 
 
 
 
Figure 3. Giardia trophozoites as van Leeuwenhoek saw them in 1681 (A) and as we see them 
in 2010 (B, C). The picture in A was adjusted by use of Photoshop CS to account for the way 
that the human eye optimizes a microscopic image (photo courtesy Brian Ford). Photo B and C 
Anders Magnusson 
 
3.2 THE PARASITE 
 
The name 
After Leeuwenhoek’s observations, it took about 200 years before the organism was 
given a name. Lambl rediscovered Giardia in 1859 and called it Cercomonas 
intestinalis. In 1882 Kunstler established the generic name Giardia for a flagellate 
(Giardia agilis) found in a tadpole. Over the years different species names have been 
proposed for the parasite infecting humans: Giardia lamblia, Giardia duodenalis, and 
Giardia intestinalis.  These three names are now used in parallel, with some regional 
and personal preferences (Adam, 2001). 
 
Giardia species 
The genus Giardia is a member of the diplomonads, a group of binucleated flagellates 
that belongs to the eukaryotic supergroup Excavata (Adl et al., 2005). Giardia is the 
only genus of diplomonads that infects humans, and its closest relative found in the 
human intestine is the uninucleate flagellate Chilomastix mesnili. The following six 
species of Giardia have been described, based on the morphology of the trophozoites 
and median bodies and the characteristics revealed by electron microscopy: 
G. intestinalis (humans and mammals), G. agilis (amphibians), G. muris (rodents), 
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G. ardae (birds), G. psittaci (birds), and G. microti (rodents) (Adam, 2001). If not 
otherwise indicated, in this thesis Giardia refers to G. intestinalis.  
 
3.2.1 Life cycle and morphology  
Like E. histolytica, Giardia has a simple life cycle that comprises a resistant infectious 
cyst stage and a mobile disease-causing trophozoite. The cysts are transmitted via 
water, food, or person-to-person contact, and it has been estimated that 10–25 cysts are 
sufficient to achieve infection (Rendtorff, 1954b). A cyst is oval in shape, measures 8–
12 µm x 7–10 µm, and has four nuclei. The nuclei are hardly visible in unstained 
preparations but are distinct after trichrome or DAPI (4'-6-diamidino-2-phenylindole) 
staining (Fig. 4A, B). Excystation is triggered by exposure to the gastric acid in the 
host’s stomach and continues in the small intestine. This process starts with a short-
lived excyzoite, which divides twice and gives rise to four trophozoites that measure 5–
9 µm x 12–15 µm and have two nuclei, eight flagella, and a median body with 
unknown function. The living trophozoite moves in a very characteristic way, like a 
―falling leaf‖, and this feature is used as a diagnostic criterion to discriminate Giardia 
trophozoites from other protozoan flagellates in fresh stool samples. The trophozoites 
are very ―photogenic‖ in Giemsa-stained preparations, appearing as a face in which the 
two nuclei form the eyes and the median body constitutes the smile (Fig. 4C). The 
trophozoites are either free or become attached to the intestinal epithelium via an 
adhesive disc. Encystation into new cysts takes place in the lower part of the small 
intestine, and the excreted cysts, which are immediately infectious, are also resistant to 
environmental factors and can survive for a long time under favorable conditions 
(Ankarklev et al., 2010). 
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Figure 4. Micrographs of Giardia showing a cyst stained with trichrome (A), another cyst 
stained with DFA + DAPI (B), and a trophozoite stained with Giemsa (C) 
 
 
3.2.2 Clinical presentation 
Although Giardia trophozoites were detected in a diarrheic stool more than 300 years 
ago, the organism was not considered pathogenic until 1978, and this assertion was 
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based on observations of symptoms such as malabsorption, and the pathology of the 
upper part of the small intestine in patients with giardiasis (Kulda and Nohýnková, 
1978; Faubert, 2000). Koch’s postulate was fulfilled in 1987, when all of five 
volunteers inoculated with the GS/M strain (assemblage B) became infected, and two 
of them also developed typical symptoms of giardiasis (Nash et al., 1987). The average 
incubation time from infection to onset of symptoms is one week but can be as long as 
three weeks (Jokipii and Jokipii, 1977). The typical patient has symptoms for at least 
one week, including foul-smelling diarrhea, nausea, abdominal cramps, flatulence, and 
intense fatigue (Petri, 2005). Prolonged diarrhea and malabsorption may also be 
present, although many of the patients have only mild diarrhea or remain 
asymptomatic, especially in endemic areas. Unlike E. histolytica, Giardia is a non-
invasive organism, and the pathogenesis is not fully understood. The disease is now 
considered multifactorial, including apoptosis of enterocytes, loss of epithelial-barrier 
function, hypersecretion of chloride ions, inhibition of brush-boarder enzymes, and 
malabsorption of glucose, water, and sodium ions (Ankarklev et al., 2010).  
 
3.3 LABORATORY DIAGNOSIS OF GIARDIASIS 
 
Microscopy 
Microscopic detection of Giardia cysts in a stool specimen, either directly in a wet 
smear or after formol-ethyl acetate concentration, is the most frequently used method 
for diagnosis of giardiasis worldwide. Less often, diagnosis is based on detection of 
trophozoites in fresh stool samples or SAF-fixed material. Compared to identification 
of Entamoeba spp., microscopy of Giardia cysts and trophozoites is more 
straightforward, and there is little risk of confusion with other parasites. Moreover, 
only ―ghost‖ cysts with an empty appearance are sometimes not recognized as 
Giardia parasites (Collins et al., 1978). However, the sensitivity of microscopy is 
quite low due to the intermittent excretion of Giardia cysts (Rendtorff, 1954b; 
Danciger and Lopez, 1975), and thus it is recommended that at least three samples be 
examined in order to rule out giardiasis. 
 
Antigen detection methods 
Quite a few commercial kits are available for detection of Giardia antigen. Two 
techniques that are often used are enzyme-linked immune-sorbent assay (ELISA) that 
assesses soluble antigens and a direct fluorescent antibody (DFA) test that detects intact 
organisms. Several studies have shown that these two methods offer greater sensitivity 
compared to light microscopy (Zimmerman and Needham, 1995; Garcia and Shimizu, 
1997), but they are not available in all parasitology laboratories due to the high cost and 
substantial workload they entail, and also limited access to the required equipment. An 
alternative technique involves a solid-phase immunochromatographic test card system 
(ImmunoCardSTAT! Cryptosporidium⁄Giardia rapid assay), which allows concurrent 
detection of Cryptosporidium and is also fast, easy to use, and does not require extra 
equipment (Johnston et al., 2003). Unfortunately, the sensitivity of such a system is 
lower than microscopy, and thus this test is not recommended for follow-up of patients 
with Giardia treatment failure (Strand et al., 2008).  
 
PCR  
Conventional single or nested PCR analyses are not often performed for diagnosing 
giardiasis, except at specialized centers. In contrast, there is increasing use of real-
time PCR as a diagnostic tool that can detect Giardia, often in combination with other 
enteric protozoa, such as Cryptosporidium spp., E. histolytica, and D. fragilis. This 
approach has proven to provide higher sensitivity compared to conventional methods, 
   15 
and it also entails a lower workload (Verweij et al., 2004; Haque et al., 2007; 
Schuurman et al., 2007; Ten Hove et al., 2007; Bruijnesteijn van Coppenraet et al., 
2009; Ten Hove et al., 2009; Calderaro et al., 2010). However, in the parts of the 
world where giardiasis is highly endemic, microscopy will probably remain the 
routine procedure for detecting stool parasites, including Giardia, for a long time to 
come.  
 
3.4 EPIDEMIOLOGY 
 
Giardia is a parasite found in all parts of the world and in a large number of 
mammals, including humans, livestock, pets, wildlife, and aquatic animals 
(Thompson, 2000; Lasek-Nesselquist et al., 2010). Several recent reports have also 
described G. intestinalis in various birds and even fish, although true infections 
remain to be confirmed in these animals (Lasek-Nesselquist et al., 2008; Yang et al., 
2010b). The scope of this thesis is limited mainly to human giardiasis, and thus 
Giardia infection in animals will be discussed in light of the potential zoonotic risk, 
not from a clinical veterinary perspective.  
 
Giardiasis worldwide 
The prevalence of Giardia in humans varies in and between countries, and it is higher 
in areas where environmental hygiene is low. According to estimates from the WHO 
about 200 million people have symptomatic giardiasis, and around 500,000 new cases 
occur each year (WHO, 1996). Studies in different European countries have indicated 
a prevalence of 1–17%, and up to 100% of the population can be infected in certain 
highly endemic areas (Plutzer et al., 2010).  
 
Giardiasis in Sweden 
In 1889, Muller made one of the earliest observations of giardiasis in Sweden, when 
he described several layers of trophozoites of what he called Cercomonas intestinalis 
(the name used by Lambl in 1859) attached to the mucosa of the small intestine of an 
executed murderer (Muller, 1889). Ruth Svensson’s studies of parasites in various 
healthy populations in the 1930s in Sweden revealed a Giardia prevalence of 4.7% in 
urban regions and 7.0% in rural areas (Svensson, 1935). In the 1970s, several 
Swedish reports were published concerning giardiasis in children at day care centers 
and among people who had traveled to Leningrad (Kettis and Magnius, 1973; Kettis 
and Thoren, 1974). No prevalence studies have been performed in Sweden since Ruth 
Svensson’s days, but in a survey of adult individuals conducted in 1996–1997, 
Giardia cysts were found in 2% of the diarrhea patients and in none of the 203 
healthy controls (Svenungsson et al., 2000).  
 
An investigation of calves in Sweden detected Giardia infections in 29% of the 
animals that were diarrheic and 23% of those that were healthy (Bjorkman et al., 
2003). Similar results were obtained when diarrheic and healthy lambs were 
investigated: 25% and 20%, respectively, were infected with Giardia (Ljungström et 
al., 2001). Another study of dogs in Sweden revealed that Giardia was common in 
puppies (33%) but rare in the adult animals, and none of the dog owners harbored 
cysts (Castor and Lindqvist, 1990). 
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3.5 MOLECULAR DIFFERENTIATION 
 
3.5.1 Assemblages and subtypes 
Giardia intestinalis consists of seven genetically different assemblages, designated A 
to G, and an additional genetic variant was recently described in seals (Lasek-
Nesselquist et al., 2010). All assemblages have similar morphology, and they cannot 
be differentiated by microscopy. Based on genetic and host-specific data, it has been 
proposed that assemblages A to G be re-classified as separate Giardia species (Monis 
et al., 2009), but this issue has not yet been settled (Table 2). Previous research based 
on enzyme analysis and DNA sequencing of isolates of Giardia adapted to growth in 
vitro have shown that each of the two assemblages A and B can be further divided 
into two main sub-assemblages, which are designated AI and AII, and BIII and BIV 
(Monis et al., 1996; Monis et al., 1999). It was long assumed that AI was the only 
zoonotic A sub-assemblage, and that AII occurred only in humans, although it has 
been shown that the latter group has a wider host range as well (Sprong et al., 2009). 
An additional sub-assemblage denoted A III has also been described (Lalle et al., 
2007), which is considered to be strictly non-zoonotic, because it has been identified 
solely in animals (mainly wild ungulates). So far, no host preferences have been 
attributed to sub-assemblages BIII and BIV. Furthermore, it is evident that more 
―subtypes‖ exist within assemblages A and B, as well as within the other 
assemblages. The nomenclature for Giardia subtypes has not been strictly 
standardized, and various researchers have used different designations for the level 
below sub-assemblage, calling it subtype, sub-genotype, subgroup, or genotype. In 
this framework and in Paper IV, the term ―subtype‖ is used to refer to the level under 
sub-assemblage, while the term ―sub-genotype‖ was used in Paper II and III. In some 
instances, Arabic numerals are also used to denote established subtypes (e.g., 
subtypes A2 and A3 at the β-giardin locus) (Caccio et al., 2002).  
 
Table 2. Giardia assemblages and proposed species names 
Assemblage Sub-
assemblage 
Host Proposed  
species name 
A AI 
AII 
AIII 
Humans and animals 
Humans and animals 
Animals 
Giardia duodenalis 
B BIII  
BIV 
Humans and animals Giardia enterica 
C  Dogs Giardia canis 
D  Dogs Giardia canis 
E  Ruminants and horses Giardia bovis 
F  Cats Giardia felis 
G  Rodents Giardia simondi 
 
3.5.2 Molecular typing methods 
Compared to other protozoan parasites, such as Cryptosporidium spp. and Plasmodium 
falciparum, genotyping techniques for Giardia are not particularly advanced. The 
following loci are most often used as markers: the small subunit ribosomal RNA 
(ssrRNA), β-giardin, glutamate dehydrogenase (gdh), and triose phosphate isomerase 
(tpi). Considering differences between these genes, tpi and gdh are the most variable, 
followed by β-giardin, and the ssrRNA gene is the most conserved. These disparities are 
mirrored in differences in substitution patterns, since the β-giardin gene shows few 
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non-synonymous changes, whereas gdh and tpi seem to tolerate amino acid 
replacements (Caccio and Ryan, 2008). The ssrRNA gene has frequently been used for 
genotyping of both human and animal isolates. This gene has a multi-copy nature that 
results in greater sensitivity of PCR compared to the sensitivities achieved when 
analyzing the other commonly used genes, and its conserved features facilitate design 
of the primer. However, the discrimination power is low for the ssrRNA gene, and 
differentiation is possible only between assemblages, not between sub-assemblages or 
subtypes. By comparison, higher resolution can be achieved for the β-giardin, tpi, and 
gdh genes, and numerous subtypes within each assemblage have been identified, many 
of them occurring only in single isolates (Sprong et al., 2009). Recently, the strategy of 
applying the 5.8S rDNA and intergenomic rRNA spacer regions (ITS1 and ITS2) for 
differentiation of all assemblages has gained attention as a useful method for both 
genotyping and identification of species other than G. intestinalis, including G. muris 
and G. microti (Caccio et al., 2010).  
 The tool used most often for identifying different assemblages has been 
conventional PCR in combination with either direct sequencing or analysis of 
restriction fragment length polymorphism (RFLP). PCR with assemblage-specific 
primers (Amar et al., 2002; Geurden et al., 2008; Levecke et al., 2009) and real-time 
PCR with assemblage-specific probes (Guy et al., 2004; Almeida et al., 2010) have also 
been described. 
 
RFLP 
The RFLP technique is frequently used to genotype protozoan parasites such as 
Cryptosporidium spp. and Leishmania spp. (Spano et al., 1997; Xiao et al., 2001; 
Marfurt et al., 2003). RFLP is simple to perform and less resource demanding 
compared to sequencing, but the information obtained is limited, and point mutations 
in the restriction sites can give rise to unexpected RFLP patterns. A number of 
investigators have described the use of PCR-RFLP methods for Giardia genotyping 
at several loci (primarily in human isolates): β-giardin (Caccio et al., 2002; Lalle et 
al., 2005b), gdh (Homan et al., 1998; Read et al., 2004), and tpi (Amar et al., 2002; 
Lalle et al., 2009). However, in the future, RFLP will probably be replaced by 
sequencing, because the latter method is becoming increasingly affordable and is 
generally more informative than RFLP.  
 
3.5.3 MLGs, mixed infections, and assemblage swapping  
The resolution of genotyping using only one gene is not considered to provide 
sufficient discriminatory power, and hence a multilocus approach has been suggested 
by Caccio and colleagues (2008). According to their proposal three markers (the β-
giardin, gdh, and tpi genes) should be used, and the sequences (subtypes) of each locus 
should be combined into multilocus genotypes (MLGs) which can make it possible to 
to enable comparison of isolates from different sources. The occurrence of mixed 
infections has also been noted lately in some investigations using assemblage-specific 
tpi primers, which allows detection of a much larger number of mixed assemblage A 
and B infections than can be done when using more general primers (Geurden et al., 
2008; Levecke et al., 2009). Another feature observed in Giardia genotyping studies is 
the occurrence of ―assemblage swapping,‖ which means that different markers can give 
rise to different results for the same isolate. This phenomenon has been attributed to 
preferential amplification of one assemblage over the other in ―true‖ mixed infections 
or to recombination between assemblages (Caccio et al., 2008; Caccio and Sprong, 
2009). Thus, it is clear that in-depth studies focusing on several loci and using 
assemblage-specific primers are needed both to clarify the issue of zoonotic 
transmission and to discern the correlation between assemblages and disease pattern.  
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3.5.4 Allelic sequence divergence  
Several investigators have observed that double peaks (overlapping nucleotides) often 
occur in sequences from assemblage B, as well as assemblages C, D, and E, but are 
rarely seen in assemblage A or F (Caccio and Ryan, 2008). This feature has been 
attributed to mixed subtype infections or allelic sequence divergence, or a 
combination of both. The frequent occurrence of double peaks in the assemblage B 
sequences also complicates assignment of isolates to sub-assemblages and to specific 
MLGs. 
 
3.6 MOLECULAR EPIDEMIOLOGY 
 
3.6.1 Giardia assemblages in humans  
Genotyping of a large number of human Giardia isolates from different parts of the 
world has demonstrated that humans are almost exclusively infected with assemblage 
A or B. Other assemblages have occasionally been found in humans: C and D (Read 
et al., 2004; Traub et al., 2004), E (Foronda et al., 2008), and F (Gelanew et al., 
2007), but these findings require further confirmation. Table 3 presents examples of 
the results of genotyping of human isolates collected worldwide (outbreak-related 
investigations are not included). According to this compilation, assemblage B 
dominates in Asia, Australia, Europe, and Latin and South America, whereas it seems 
that assemblage A predominates in Africa. It is not clear whether these data reflect 
the different populations investigated, the different geographical sites, or the various 
methods used. Table 4 shows the incidence of assemblages in studies using only one 
marker (data extracted from Table 3). According to analysis based on the tpi marker, 
assemblage B is twice as common as assemblage A, whereas the opposite results are 
obtained by use of the β-giardin marker (i.e., twice as many assemblage A as 
assemblage B isolates). A similar trend is seen among the sequences deposited in the 
ZoopNet database (Sprong et al., 2009). The reason for these discrepancies is 
unknown, although it has been speculated that primer sequence mismatches might 
reduce the ability to amplify certain assemblage B isolates at the β-giardin locus 
(Robertson 2007).  
 
Table 3. Distribution of assemblages A and B in 2471 human cases of giardiasis 
An asterix* indicates that correlation between assemblages and symptoms was investigated 
 
Origin No. of 
isolates 
Loci tested Ass A Ass 
B 
Ass 
A+B 
Reference 
Argentina 28 tpi  0 28 0 (Molina et al., 2007) 
Argentina 43 tpi  3 40 0 (Minvielle et al., 2008) 
Brazil 62 ß-giardin  62 0 0 (Volotao et al., 2007) 
Brazil 37 gdh  29 8 0 (Souza et al., 2007) 
Brazil* 58 ssrRNA 9 43 6 (Kohli et al., 2008) 
Cuba* 20 ß-giardin, gdh  9 11 0 (Pelayo et al., 2003) 
Mexico 9 ß-giardin  9 0 0 (Lalle et al., 2005a) 
Nicaragua 119 ß-giardin, gdh 25 92 2 (Lebbad et al., 2008) 
Peru 16 gdh  10 6 0 (Perez Cordon et al., 2008) 
Peru 25 tpi  6 19 0 (Sulaiman et al., 2003) 
Canada 15 ß-giardin 3 9 3 (Guy et al., 2004) 
Total 
America 
432  165 256 11   
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Australia 8 gdh, ssrRNA 2 6 0 (Read et al., 2004) 
Australia* 23 ssrRNA 7 16 0 (Read et al., 2002) 
Australia 124 gdh, ssrRNA 31 93 0  (Yang et al., 2010a) 
New Zealand 30 ß-giardin 23 7 0  (Winkworth et al., 2008) 
Total Australia 
and New Zealand 
185  63 122 0   
Bangladesh* 267 ssrRNA, tpi 20 231 16 (Haque et al., 2005) 
India* 101 tpi 7 88 6 (Ajjampur et al., 2009) 
India 16 tpi 5 8 3 (Traub et al., 2004) 
Malaysia 42 ssrRNA 1 41 0 (Mahdy et al., 2009) 
Nepal 35 ssrRNA, tpi 7 26 2 (Singh et al., 2009) 
Palestine 8 gdh 5 3 0 (Hussein et al., 2009) 
The Philippines 133 tpi 18 83 32 (Yason and Rivera, 2007) 
Thailand 61 ß-giardin, gdh, 
tpi 
5 31 25 (Tungtrongchitr et al., 2010) 
Thailand 12 gdh 5 7 0 (Ratanapo et al., 2008)  
Thailand 30 ß-giardin 12 17 1 (Kosuwin et al., 2010) 
Total Asia 705  85 535 85   
Egypt* 41 tpi 31 8 2 (Helmy et al., 2009) 
Egypt 17 tpi 1 16 0 (Foronda et al., 2008) 
Egypt* 87 tpi 58 10 19 (Abdel-Moneim and Sultan, 
2008) 
Ethiopia* 52 ß-giardin 31 13 8 (Gelanew et al., 2007) 
Ivory Coast 14 tpi, gdh 0 14 0 (Bertrand et al., 2005) 
Western Sahara 36 tpi, gdh 16 18 2 (Lalle et al., 2009) 
Total Africa 247  137 79 31   
Albania 22 ssrRNA 10 12 0 (Berrilli et al., 2006) 
Belgium 72 ß-giardin, gdh, 
tpi 
16 30 26 (Geurden et al., 2009b) 
France 25 tpi, gdh 9 16 0 (Bertrand et al., 2005) 
Italy 11 ß-giardin 5 5 1 (Giangaspero et al., 2007) 
Italy 30 ß-giardin 24 6 0 (Caccio et al., 2002) 
Italy 37 ß-giardin 17 15 5 (Lalle et al., 2005b) 
Italy 42 ssrRNA 19 13 10 (Giangaspero et al., 2007) 
Italy 68 ssrRNA,  
ß-giardin 
23 45 0 (Calderaro et al., 2010) 
Norway 63 ß-giardin, gdh, 4 59 0 (Robertson et al., 2007) 
Portugal 7 ß-giardin 2 5 0 (Almeida et al., 2006)  
Portugal 25 tpi, ß-giardin 25 0 0 (Sousa et al., 2006) 
Spain* 108 tpi 43 61 4 (Sahagun et al., 2008) 
The Netherlands 98 ssrRNA, gdh 32 64 2 (van der Giessen et al., 2006)  
The Netherlands* 18 gdh 9 9 0 (Homan and Mank, 2001) 
Turkey* 44 tpi 19 25 0 (Aydin et al., 2004)  
UK* 199 ssrRNA, tpi 48 145 6 (Breathnach et al., 2010) 
UK 33 tpi 9 21 3 (Amar et al., 2003) 
Total Europe 902  314 531 57   
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Table 4. Assemblage incidence in isolates genotyped at one locus only (data extracted from 
Table 3) 
 
Locus No. of isolates Assemblage 
  A B A+B 
tpi  676 200 407 69 
β-giardin 283 188 77 18 
gdh 91 58 33 0 
ssrRNA 187 46 125 16 
Total 1237 492 642 103 
 
 
3.6.2 Giardia assemblages in animals 
 
Cats and dogs 
Quite a few genotyping studies have included Giardia isolates from cats. A recent 
review identified only 11 investigations in which at least one cat isolate was 
genotyped (Ballweber et al., 2010). The host-specific assemblage F was more 
common (44 isolates) than the potentially zoonotic assemblage A (30 isolates), and 
sub-genotyping of a limited number of the assemblage A isolates revealed mainly 
sub-assemblage AI. We found similar proportions of assemblage F and A in cats in 
Sweden, although no classical sub-assemblages AI or AII variants were identified 
(Paper III).  
 
Dogs have been studied more extensively than cats, which has revealed that the host-
specific assemblages (C and D) also predominate in canines, although assemblage A 
and to some extent assemblage B are found as well. Mixed-assemblage infections are 
frequently identified in dogs (Sprong et al., 2009; Ballweber et al., 2010). Most 
researchers performing sub-genotyping of assemblage A isolates have detected sub-
assemblage AI. Notably, in a study conducted in Belgium, 38 of 119 successfully 
genotyped canine isolates were identical to subtype A2 or A3 (at the β-giardin gene) 
but none were identical to sub-assemblage AI (Claerebout et al., 2009). By 
comparison, dogs investigated in Sweden were found to harbor almost exclusively the 
host-specific assemblages C and D, and only one of 31 dogs in that study was 
infected with assemblage A (Paper III). 
 
Smaller pets 
Although Giardia infections are well recognized in smaller pets like rabbits, guinea 
pigs, and hamsters, few researchers have included such animals in their genotyping 
studies. Notably, in one of the few documented foodborne outbreaks of giardiasis, the 
food preparer’s infected pet rabbit was highly suspected, although no genotyping was 
performed at the time (Porter et al., 1990). In our investigation in Sweden (Paper III), 
assemblage B was identified in one rabbit and one guinea pig, and as far as we know 
these animals lack host-specific assemblages, and thus assemblage A or B could be 
expected. Indeed, this was demonstrated in an Italian study that included two rabbit 
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isolates, one of which was found to contain assemblage A and the other assemblages 
A and B (Giangaspero et al., 2007). 
 
Livestock 
Genotyping studies worldwide have included a large number of isolates from cattle 
and sheep, and to a lesser extent also goats, pigs, and horses. In livestock, it seems 
that assemblage E is most prevalent, followed by assemblage A, although there are 
some exceptions. Considering investigations of cattle samples, assemblages E and B 
have been detected in Canada (Coklin et al., 2007), whereas only assemblages A and 
B (no assemblage E) were found in New Zealand (Winkworth et al., 2008). Mixed 
assemblage infections were reported in only a few of the cited studies, however when 
Geurden et al. (2008) used assemblage-specific primers to study calves in Belgium, 
these researchers found that 31% of the investigated samples contained both 
assemblages A and E. In Sweden, we found only assemblage E in cattle, whereas 
several of the sheep samples we investigated contained variants of assemblage A 
(Paper III). 
 
Non-human primates 
Non-human primates carry the same Giardia assemblages as humans, namely, A and 
B. Genotyping of isolates from gorillas and howler monkeys in Uganda and Brazil, 
respectively, detected only assemblage A (Graczyk et al., 2002; Volotao et al., 2008), 
whereas a study of various captive non-human primates in Belgium revealed both A 
and B, and also showed that mixed assemblage infections were common (Levecke et 
al., 2009).  
 
Wildlife 
This group includes various mammals, such as wild ruminants (moose, deer, buffalos, 
and muskoxen), carnivores (foxes, coyotes), rodents (rats, voles), and aquatic animals 
(beavers, seals). Rodents are usually infected with the host-specific assemblage G, 
whereas AI and AIII are the most prevalent sub-assemblages in wild ruminants. Both 
assemblages A and B have been identified in foxes, beavers, and seals (Hamnes et al., 
2007; Lasek-Nesselquist et al., 2008). 
 
3.7 ZOONOTIC ASPECTS 
 
In 1979, the WHO elected to include giardiasis on their list of diseases that might be 
zoonotic and this decision was based on the occurrence of large-scale waterborne 
outbreaks of giardiasis in North America, in which wild animals were assumed to play 
a major role (WHO, 1979). WHO officials also referred to a report recounting 
experimental infections of humans and animals with Giardia cysts obtained from 
beavers (Davies and Hibler, 1979). Beavers are the animals that are most widely 
suspected of being sources of giardiasis in the United States and Canada, but the 
opposite scenario is actually more likely: beavers are probably infected through water 
contaminated by humans (Xiao and Fayer, 2008). In the first fully described 
experimental infection of a human volunteer with Giardia obtained from a non-human 
source, the cysts used were isolated from a giant pouched rat carrying assemblage B 
(Majewska, 1994). 
 
Sub-assemblage AI and, to a lesser extent, also sub-assemblage A II and assemblage B 
are considered to have zoonotic potential. Many reports have claimed findings of 
zoonotic genotypes, but few studies have included both human and animal samples 
from the same area. Nevertheless, at least four investigations have proposed zoonotic 
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transmission between animals and humans living in the same communities. In the first 
of these, Traub and colleagues (2004) found that humans and dogs in two households in 
northern India carried the same A or B genotypes. The second study (Inpankaew et al., 
2007) examined samples from humans and dogs at 20 different temples in Bangkok, 
and a notable observation was that, among the sequenced isolates, assemblage A 
occurred in one dog and two monks at the same monastery. The third investigation 
(Marangi et al., 2009) showed that six children and eight dogs from a closed 
community in Italy harbored sequences exhibiting 99.5% identity to sub-assemblage 
AI. The fourth study (Winkworth et al., 2008) included samples from 30 humans and 
40 calves from the same area in New Zealand, and it was found that isolates from 13 of 
the humans and 24 of the calves had identical sub-assemblage AI sequences. 
Furthermore, isolates from four of the humans and four of the calves had identical 
assemblage B sequences and, interestingly, this particular subtype was also found to be 
common in human isolates in Belgium (Geurden et al., 2009b), as well as in 18 isolates 
analyzed in our study of human giardiasis in Sweden (Paper IV). 
 
Of the four investigations discussed above, only the one conducted in India (Traub et 
al., 2004) used more than one marker (i.e., ssrRNA and tpi), and the results of 
sequencing at the two loci gave inconsistent results for samples from both humans and 
animals (assemblage swapping). The study in Bangkok (Inpankaew et al., 2007), used 
the ssrRNA locus, and the remaining two investigations sequenced the β-giardin gene. 
Notably the β-giardin gene fragments sequenced in the last two studies differed 
substantially in length (191 and 511bp, respectively).  
 
Sprong and colleagues investigated the zoonotic potential of Giardia by using a large 
number of sequences submitted to the ZoopNet databank (Sprong et al., 2009). These 
researchers compared sequences from 1,440 animal and 978 human isolates analyzed 
at four genetic loci (ssrRNA, β-giardin, gdh, and tpi) and found that both assemblages 
A and B had an evident zoonotic potential at the level of assemblages and sub-
assemblages. However, when a multilocus (β-giardin, gdh, and tpi) approach was 
used, a zoonotic potential was apparent for only two MLGs, both from assemblage A. 
In their article zoonotic potential was defined as an identical Giardia genotype 
isolated both from animal and humans, and they did not consider epidemiological 
parameters. They also found that several isolates were assigned to different 
assemblages at different loci, which further complicated the picture. 
 
3.8 ASSEMBLAGE AND DISEASE 
 
Several of the studies included in Table 3 explored intestinal symptoms in relation to 
assemblages. A number of investigators observed that clinical symptoms were 
associated with assemblage A (Read et al., 2002; Aydin et al., 2004; Haque et al., 2005; 
Ajjampur et al., 2009), whereas others found a stronger relationship with assemblage B 
(Pelayo et al., 2003; Gelanew et al., 2007). Also, two studies demonstrated that 
assemblage B exhibited more extensive association with persistent symptoms, while 
assemblage A was found in connection with intermittent diarrhea (Homan and Mank, 
2001; Helmy et al., 2009). Sahagun and colleagues (2008) found a correlation between 
assemblage A and symptoms in patients less than five years of age, whereas other 
investigators noted that fever was more common in assemblage A patients, but found 
no additional associations (Breathnach et al., 2010). Moreover, no correlation was 
detected between assemblages and symptoms in analyses performed in Egypt and 
Brazil (Abdel-Moneim and Sultan, 2008; Kohli et al., 2008). Most of the mentioned 
studies used one or two markers, and it is noteworthy that the tpi gene was more often 
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found to be associated with symptomatic assemblage A patients than the gdh and β-
giardin genes. It is not yet known whether this is merely a coincidence, or if it mirrors 
the ability of different primers to amplify certain assemblages. The published results 
also suggest that the less prominent assemblage in an area might be the one that is most 
prone to produce symptomatic infection, as was seen for assemblage A in two studies 
conducted in Asia (Haque et al., 2005; Ajjampur et al., 2009). 
 
3.9 MULTI LOCUS GENOTYPING AS A TOOL FOR SOURCE TRACING 
 
In outbreak situations, it is of great interest to trace the source of infection. Waterborne 
outbreaks of Giardia are quite common, but source tracing is seldom successful. This 
might be due primarily to the relatively long prepatient period of the infection; once the 
symptoms appear and the diagnosis is established, the source is eliminated. Another 
plausible reason is that the number of cysts present in contaminated water is usually 
low, and thus detection requires very sensitive PCR methods. In a waterborne outbreak 
in Bergen, Norway, there were 1300 laboratory-confirmed cases, and genotyping of 
stool samples revealed different subtypes of assemblage B; however, molecular 
analysis of the few Giardia cysts found in the drinking water four weeks after the onset 
of the outbreak was not successful (Robertson et al., 2006). Foodborne outbreaks of 
giardiasis are rarely described, and no successful genotyping has been reported. 
Genotyping performed in connection with outbreaks at day care centers revealed 
assemblage B in all amplified isolates in one study (Amar et al., 2002) and assemblage 
A in all isolates in another investigation conducted in Sweden (Svenungsson et al., 
2007). Regrettably, the methods used in those two studies (i.e., assemblage-specific tpi 
PCR and sequencing of the β-giardin gene, respectively) are not discriminatory enough 
to allow correlation of cases.  
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4 AIMS 
 
The general aim of this thesis was to differentiate and characterize intestinal protozoa 
through the introduction and development of molecular methods.  
 
Specific aims: 
 to estimate the proportion of Entamoeba histolytica and Entamoeba dispar in 
patients with amoebic infections diagnosed by microscopy (Paper I); 
 
 to investigate Giardia assemblages in human and animal isolates from 
Sweden and Nicaragua (Paper II, III, IV); 
 
 to genotype Giardia isolates from humans and animals, and to investigate 
their zoonotic potential (Paper III, IV); 
 
 to investigate the correlation between Giardia assemblages and clinical 
symptoms (Paper IV); 
 
 to evaluate sequence-based multilocus genotyping as a potential tool to 
investigate different Giardia isolates from humans and animals (Paper III and 
IV); 
 
Ethical clearance was obtained for Paper I, II, III and IV.  
 
   25 
5 ENTAMOEBA IN SWEDEN (PAPER I) 
 
5.1 STUDY DESIGN AND STUDY POPULATION 
In Sweden, routine stool parasitology is performed at around 30 different laboratories. 
At the time this study was conducted (2001–2002), none of these laboratories used 
molecular analyses or antigen tests to differentiate Entamoeba species, and thus 
reporting as E. histolytica/E. dispar when quadrinucleate cysts were found, leaving it 
up to the physician to decide whether or not treatment should be implemented. 
According to the Swedish Communicable Diseases Act, it was mandatory for clinicians 
to submit notification of identified Entamoeba infections, and those records indicated 
that around 400 cases were detected each year. At that time, the majority of those cases 
were probably treated as true E. histolytica infections, and thus there was an obvious 
need for specific species diagnosis. All infectious disease clinics and parasitology 
laboratories in the country were given information about our study and were invited to 
participate. The inclusion criterion was the detection of E. histolytica/E. dispar 
parasites by microscopy. 
 
There were a few obstacles to overcome before we could begin the study. The first 
problem was the fact that formalin or SAF fixative was frequently used as a transport 
medium for stool samples sent to the parasitology laboratories for examination. Initial 
assays performed at our laboratory at SMI had shown inconsistent PCR results for 
DNA extracted from formalin- or SAF-fixed samples. In short, the sensitivity of PCR 
was hampered when analyzing stool specimens that had been exposed to either of the 
mentioned fixatives, and this effect appeared to be both dose and time dependent. We 
realized that it was not suitable to perform PCR on the original stool sample, and thus it 
was necessary for the parasitology laboratories to inform the doctors in charge that new 
samples had to be sent to us at SMI in order to achieve species differentiation. The next 
obstacle to overcome was that Entamoeba DNA degrades over time in unfixed stool 
samples. This was particularly apparent in samples containing mainly trophozoites, as 
would be the case in patients with E. histolytica dysentery. Figure 5 shows how the 
sensitivity of PCR diminished over time in a sample containing E. dispar trophozoites. 
The sample was kept at room temperature, and DNA was extracted at different time 
intervals. After 48 hours, no detectable DNA was amplified. Due to limited access to 
true E. histolytica samples, we used a stool specimen containing E. dispar parasites, 
because we assumed it would provide comparable results.  
 
 
 
 
 
 
 
 
 
 
 
Figure 5. PCR analysis of Entamoeba dispar DNA extracted from a stool sample at different 
times after collection. Results: lane 1, 0 h; lane 2, 2 h; lane 3, 4 h; lane 4, 6 h; lane 5, 8 h; lane 6, 
10 h; lane 7, 24 h; lane 8, 48 h; lanes 9 and 10, negative controls; lane 11, E. dispar control 
 
M    1     2   3    4    5    6    7    8    9  10   11 
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We also found that fixation in 70% ethanol preserved the Entamoeba DNA quite well, 
at least on the lab bench, which prompted us to evaluate ethanol as a transport medium 
for stool samples intended for Entamoeba PCR. All participants in the study received a 
―kit‖ containing sampling instructions, vials with and without ethanol, request forms, 
and a stamped envelope addressed to the SMI. DNA extraction and PCR were 
performed using a commercial kit for DNA extraction (QIAamp
TM 
DNA mini kit) and 
conventional single PCR methods (Clark and Diamond, 1991b; Tachibana et al., 1991). 
The primers used for Entamoeba differentiation are listed in Table 5. 
 
Table 5. Primers used for Entamoeba differentiation* 
 
Primer 
ID 
Primer sequence (5´–3´) Locus Target bp Reference 
PspF 
 
PspR 
GGCCAATTCATTCAATG
AATTGAG 
CTCAGATCTAGAAACAA
TGCTTCTC 
ssrRNA E. histolytica 876 (Clark and 
Diamond, 
1991b) 
NPspF 
 
NPspR 
GGCCAATTTATGTAAGT
AAATTGAG 
CTTGGATTTAGAAACAA
TGTTTCTTC 
ssrRNA E. dispar 878 (Clark and 
Diamond, 
1991b) 
P11 
 
P12 
GGAGGAGTAGGAAAGTT
GAC 
TTCTTGCAATTCCTGCTT
CGA 
PRX
a
 30-
kDa 
protein 
E. histolytica 100 (Tachibana 
et al., 1991) 
EntamI 
 
EntamII 
GTTGATCCTGCCAGTATT
ATATG 
CACTATTGGAGCTGG 
AATTAC 
ssrRNA Entamoeba 
spp 
580
b
 (Verweij et 
al., 2001) 
*The annealing temperature was 55 °C for all primers.
 
a
Peroxiredoxin gene
 
b
Amplicon size depends
 
on the Entamoeba species; 579–580 bp for the E. polecki complex. 
 
5.2 RESULTS AND DISCUSSION 
 
Altogether, stool samples from 207 patients were received and analyzed by microscopy 
and PCR at SMI. Microscopy performed after concentration of the unfixed sample 
detected the E. histolytica /E. dispar complex in 161 patients, all of whom were 
positive in PCR (10 for E. histolytica and 151 for E. dispar). In addition, samples from 
14 patients who were negative by microscopy were positive for E. dispar in PCR 
analysis. In seven of those cases only the ethanol fixed samples were positive in PCR, 
indicating that degradation of DNA occurred in unfixed samples during transport.  
 
In all, only 5.7% of the PCR-positive samples contained E. histolytica DNA. This low 
proportion of E. histolytica compared to E. dispar agrees with data from settings 
similar to ours, such as Australia, Canada, Greece, Spain, and the Netherlands (Verweij 
et al., 2000; Evangelopoulos et al., 2001; Gonin and Trudel, 2003; Visser et al., 2006; 
Fotedar et al., 2007b; Gutierrez-Cisneros et al., 2010). After conclusion of our study, 
differentiation of Entamoeba species became a part of routine analyses at SMI. The 
results of PCR performed on stool specimens from April 2001 to December 2009 
indicate that E. histolytica infections have never represented more than 10% of the total 
number of positive PCR reactions per year (Table 6). 
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Table 6. PCR differentiation of E. histolytica and E. dispar in stool samples 2001–2009 
 
a 
Total number of E. histolytica (% of all positive PCR)  
 
No mixed infections with E. histolytica and E. dispar were found during the study 
period, and the same absence of mixed infection has also been observed in other non-
endemic areas. This reflects either the true situation or the fact that only DNA from the 
most dominant species is amplified in PCR. Since 2003, we have used two primer pairs 
that target different E. histolytica loci in all samples investigated by PCR (Table 5). 
Despite that, mixed infections have continued to be very rare, or, more precisely, has 
occurred only once, in a child from Somalia. 
 
Samples from 46 patients were negative for E. histolytica/E. dispar by microscopy 
performed at SMI. Fourteen of those specimens contained E. dispar DNA, whereas the 
remaining 32 were negative in both PCRs. All but two of those patients had sent in 
paired samples (one unfixed, one ethanol fixed), and hence there was probably no DNA 
degradation. A shortcoming of our study was the lack of access to the original samples 
and the time delay between initial diagnosis and the second sample collected for 
Entamoeba PCR and thus one or more of the following scenarios explain the negative 
results of microscopy and PCR: 
 
a) patients were treated after initial diagnosis and before providing the 
second sample; 
b) spontaneous cure could have occurred, especially if there was a 
long delay between the first and the second sample; 
c) intermittent excretion of cysts gave false-negative microscopy and 
PCR results; 
d) the initial diagnosis was mistakenly based on amoeba species other 
than E. histolytica/E. dispar. 
 
Scenarios a and b were out of our control, whereas c was already under partial 
monitoring during the study period. We received two or three samples (taken on 
different occasions) from 17 of the study patients, and in only one of those cases did the 
findings change from negative to positive.  
 
 
Entamoeba 
histolytica 
Entamoeba 
dispar 
Negative in 
PCR 
Total 
PCR 
April 2001–Dec 
2002 
10 (5.7%)
a
 
 
165 32 207 
2003 4 (5.7%) 66 24 94 
2004 3 (6.6%) 42 18 63 
2005 6 (7.8%) 71 37 114 
2006 5 (4.5%) 105 29 139 
2007 8 (6.1%) 122 33 163 
2008 8 (6.9%) 115 33 156 
2009 11 (8.3%) 121 - - 
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Scenario d is a more delicate issue. Thirty-two patients had samples that were negative 
for E. histolytica and/or E. dispar in microscopy and PCR performed at SMI, and 
samples from 22 of those subjects were found to contain cysts of other amoeba species 
(Table 7). Since we did not have access to the original samples, we can only suspect 
that the initial diagnosis was incorrect in those cases. Over the years, we have seen the 
same trend as during the study period, namely, that 15–30% of the samples sent to SMI 
for species differentiation are negative by PCR (Table 6), and that around half of the 
PCR-negative samples contain amoeba species other than E. histolytica/E. dispar. 
Microscopy of Entamoeba cysts is a real challenge, and studies in other countries such 
as Thailand, Egypt, Ethiopia, and Nicaragua have reported experiences similar to ours 
(Kebede et al., 2003; Parija and Khairnar, 2005; Hamzah et al., 2006; Leiva et al., 
2006). This difficulty to differentiate intestinal protozoa was also noticed in a European 
multicenter investigation in which only fair or moderate agreement between reference 
laboratories was found for most Entamoeba species (Utzinger et al., 2010).  
 
Table 7. Microscopy of 32 samples that were PCR negative for E. histolytica and E. dispar 
 
Parasite species detected by microscopy No of samples 
 
E. hartmanni 6 
E. hartmanni + E. coli 2 
E. hartmanni + I. butschlii 1 
E. coli 8 
E. coli + I. butschlii 1 
I. butschlii 1 
E. hartmanni + I. butschlii + G. intestinalis 1 
E. polecki 2 
G. intestinalis 1 
E. histolytica/E. dispar 0 
No cysts found 9 
Total 32 
 
 
In our laboratory, we have had access to a monoclonal antibody (kindly provided by 
Hugo Lujan, Catholic University of Córdoba, Argentina) that can distinguish between 
the E. histolytica/E. dispar complex and cysts of other amoeba species commonly 
found in humans, but unfortunately not between E. histolytica and E. dispar cysts 
(Fig. 6).  
 
 
 
 
 
 
 
 
 
 
Figure 6. E. histolytica/E. dispar cysts stained with a monoclonal antibody 
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Nevertheless, this antibody has been a very valuable complement to ordinary 
microscopy in cases involving cysts that were difficult to identify, and it has been 
especially useful for separating cysts of E. polecki type from immature uninucleate 
E. histolytica/E. dispar cysts. Cysts of E. polecki occurred during the study period and 
have appeared intermittently since then. Due to this infrequent incidence and the 
similarity to immature E. histolytica/E. dispar cysts, it is difficult for local laboratories 
to identify these cysts.  
 
The final diagnosis of E. polecki is made by PCR sequencing, either after amplification 
by universal Entamoeba primers (Table 5) or by use of primers specific for uninucleate 
Entamoeba species (Stensvold et al. manuscript in preparation). Interestingly, almost 
all samples containing uninucleate cysts that have been analyzed in our laboratory since 
2001 have had a genetic variant of E. polecki hitherto identified only in humans. Of the 
other three variants of uninucleated cysts that are occasionally discovered in humans, E. 
polecki (pigs), E. chattoni (monkeys), and E. struthionis (ostriches), only E  struthionis 
has been observed in two of our patients. Based on genetic data, these four variants are 
now considered one species, E. polecki that comprises four different subtypes 
(Stensvold et al. manuscript in preparation). 
 
From the beginning of our study in 2001 up to 2009, 55 patients were diagnosed with 
E. histolytica DNA in their stool samples (Tables 6 and 8), and 22 patients were found 
to have E. histolytica DNA in abscess material. As shown in Table 8, most of the 
infections involving both intestinal amoebiasis and ALA originated in Asia. 
Furthermore, two patients with intestinal amoebiasis had almost certainly been infected 
in Sweden; one of these individuals was probably infected by her partner who was 
diagnosed with E. histolytica/E. dispar cysts after a visit to Thailand (PCR was not 
performed), whereas no likely source of infection was determined for the other patient. 
The occurrence of domestic E. histolytica infections in other countries in Western 
Europe is not known, although it appears to be low, since only few reports, (two from 
Italy and two from the Netherlands) were found in a PubMed search (Gatti et al., 1995; 
Vreden et al., 2000; Gatti et al., 2002; Edeling et al., 2004). 
 
Table 8. Origin of cases of E. histolytica infection detected by PCR analysis of stool samples or 
liver aspirates 2001–2009 
 
 Sweden Europe Asia Africa South 
America 
Origin not 
known 
Total 
Stool 
samples 
2 3 23 6 8
a
 13 55 
Liver 
aspirates 
0 0 14 4 3
a
 1 22 
a
One patient from Brazil was positive for E. histolytica in both stool and liver abscess material. 
 
Future work on Entamoeba in Sweden will include application of real-time PCR at our 
laboratory and also implementation of differentiation of E. histolytica/E. dispar at 
different local microbiological laboratories. This work will include a new approach to 
collection of fecal specimens in which use of the combination of SAF-fixed and 
unfixed samples should enable us to solve most of the difficulties related to fecal 
parasitology. 
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6 GIARDIA IN NICARAGUA AND SWEDEN (PAPER II, 
III AND IV) 
6.1 STUDY POPULATIONS  
 
6.1.1 Giardia in Nicaragua (Paper II) 
In Nicaragua, as in the rest of Latin America, Giardia infection is common and 
contributes to the diarrheal disease burden of children (Tellez et al., 1997). At the time 
we performed this study (2002–2003) few attempts had yet been made to genotype 
Giardia isolates in Latin America. Our work was done in cooperation with Universidad 
Nacional Autónoma de Nicaragua (UNAN) in León, Nicaragua, and it was based on 
human stool samples (n = 136) that had already been collected for other purposes and 
had been found to contain Giardia cysts/trophozoites by light microscopy. Inasmuch as 
many of the inhabitants in the study area were dog owners, and the dogs were allowed 
to roam freely in the neighborhoods, we also performed microscopy to screen 100 
canine samples for Giardia cysts, and those that were found to contain cysts were 
included in our molecular analyses.  
 
6.1.2 Swedish animals (Paper III) 
In Sweden, Giardia infection in animals has received little attention, and no Giardia 
isolates from animals had been genotyped prior to our study. Our goal was to identify 
Giardia assemblages in various animal species, including livestock, pets, and wild life, 
and to determine the host specificity and zoonotic potential of the assemblages that 
were found. To obtain animal samples, we cooperated with two of the largest 
laboratories performing veterinary diagnostic parasitology in Sweden: the National 
Veterinary Institute in Uppsala and VIDILAB in Enköping. These two facilities do not 
routinely investigate all samples for Giardia, and hence it took considerable time to 
collect isolates from various sources and representing all of the different assemblages 
(2002–2008). Another impediment was that parasitological examination of animal 
samples is frequently performed on fecal samples that are pooled (by either the animal 
keeper or the staff at the diagnostic laboratory). This was a new experience for us, 
because in human parasitology each specimen represents a single patient. Thus, many 
of the animal samples had to be rejected from the study, and only pooled samples (two 
from sheep, four from cats, and 11 from dogs) that contained unique or otherwise 
interesting genotypes were included.  
 
6.1.3 Swedish patients (Paper IV) 
Prior to the study reported in Paper IV, the only human Giardia isolates that had been 
genotyped in Sweden were from an outbreak at a nursery school, and analysis at the ß-
giardin locus showed that they were exclusively of subtype A3 (Svenungsson et al., 
2007). Our present investigation was conducted between May 2007 and April 2009 in 
cooperation with a nearby hospital laboratory that perform diagnostic parasitology (the 
Department of Clinical Microbiology, Karolinska University Hospital, Stockholm) and 
the Department of Communicable Disease Control and Prevention in Stockholm 
(Smittskydd Stockholm). Fecal samples that had not been preserved in formalin or SAF 
fixative and had been diagnosed with Giardia parasites were forwarded to SMI for 
further analyses. A questionnaire concerning symptoms, recent traveling, and possible 
routes of transmission was sent to all patients by mail. In some cases, the patients were 
also interviewed by telephone.  
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6.2 METHODS (PAPER II, III AND IV) 
 
6.2.1 Preservation of fecal samples and DNA extraction 
Many studies of intestinal protozoa are carried out in developing countries that have 
limited laboratory resources, and thus there is often a time delay before DNA extraction 
can be performed. The results of our investigation of Entamoeba spp. had shown that 
ethanol fixation was useful for preserving Entamoeba DNA from human samples, and 
hence we applied this approach to Giardia DNA as well. Some of the human samples 
collected in Nicaragua (n = 33) were subjected to DNA extraction in Leon, and the 
remaining human samples (n = 103) were kept in ethanol at 4 °C for 3–10 months until 
transportation to Sweden was available. This approach was quite successful, as 
indicated by amplification at one or two loci in 86% (119/136) of the samples. On the 
other hand, initial attempts to preserve feces from Nicaraguan dogs directly in ethanol 
before DNA extraction were disappointing, since amplification failed in all samples, 
despite positive microscopy for Giardia. In a subsequent collection of canine fecal 
samples, the cysts were isolated on a sucrose gradient (on the spot in Leon), fixed in 
ethanol and thereafter transported to Sweden. This time the results were encouraging, 
because all microscopy-positive canine samples (n = 8) were successfully genotyped. 
In later analyses conducted on specimens collected in Sweden, cyst isolation on a 
sucrose gradient was used for all Giardia samples from animals, whereas Giardia DNA 
was extracted directly from human stool samples (usually ethanol fixed). The cysts 
were disrupted by the use of a Bead-Beater (Biospec Products Inc., Bartlesville, OK, 
USA) before performing extraction using a QIAamp
TM 
DNA mini kit. In our 
laboratory, this combination of isolation on a sucrose gradient (mainly for animal 
samples), mechanical disruption of cysts, and spin column purification has led to 
successful DNA extraction for Giardia PCR, as well as for PCR analysis of other 
intestinal protozoa (Entamoeba spp., Cryptosporidium spp., and Microsporidia spp.). 
 
6.2.2 Molecular methods 
Primers used for Giardia genotyping in the present research are listed in Table 9. 
AmpiTaqGold (Applied Biosystems) was employed in all PCR reactions. RFLP was 
performed on amplicons generated from β-giardin, tpi, and gdh PCR according to 
published methods (Caccio et al., 2002; Read et al., 2004; Lalle et al., 2005b; Lalle et 
al., 2009). PCR products came mainly from nested or semi-nested amplification and in 
some cases also from single PCR, and they were purified using ExoSAP-IT 
(Fermentas) and sequenced in both directions at SMI using appropriate primers and the 
Big Dye Terminator V3.1 Cycle Sequencing Kit (Applied Biosystems), or they were 
sent to AGOWA (Germany) for sequencing. Chromatograms and sequences were 
examined manually and aligned using the BioEdit sequence analysis program 
(http://www.mbio.ncsu.edu/BioEdit/page2.html). Nucleotide sequences were compared 
with sequences in the GenBank database by use of the BLAST tool 
(http://www.ncbi.nlm.nih.gov/blast/) and also with locally available sequences by 
applying the BioEdit sequence analysis program. 
 
6.2.3 Phylogenetic analyses 
Phylogenetic trees were constructed to determine the genetic relationships between 
different Giardia isolates. New sequences were combined with reference sequences of 
representative isolates from different assemblages and sub-assemblages. The trees were 
generated by maximum likelihood analysis using the generalized time-reversible (GTR) 
substitution model and among-site rate variation. More detailed information is given in 
the methods sections of Papers II, III, and IV.  
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6.3 RESULT AND DISCUSSION 
 
6.3.1 Nicaragua study (Paper II) 
In this investigation, we examined the distribution of Giardia assemblages in humans 
and dogs in Leon, Nicaragua. Initially, all 136 human samples were subjected to single 
PCR and RFLP analysis at the ß-giardin locus (Caccio et al 2002). Since that approach 
gave information only on assemblage type, we also performed PCR with subsequent 
sequencing of the ß-giardin and gdh genes in a limited number of human samples (n = 
42). The concordance between the two loci in those samples was good, and the only 
discrepancy found was that two isolates, determined as single assemblage A infections 
at the ß-giardin locus, were identified as mixed assemblage A and B infections at the 
gdh locus. We also noted that assemblage B (79%) was more common than assemblage 
A (21%). This finding is in contrast with studies performed in Mexico and Brazil that 
detected only assemblage A (Lalle et al., 2005a; Volotao et al., 2007) but it agrees with 
more recent investigations conducted in South America, which revealed a 
predominance of assemblage B (Kohli et al., 2008; Minvielle et al., 2008). We also 
demonstrated that assemblage B sequences were highly polymorphic compared to 
sequences from assemblage A, the latter showing only two subtypes (A2 and A3) at the 
β-giardin locus. The eight canine samples were investigated at the ssrRNA, β-giardin, 
and gdh loci, and all of them were found to contain the host-specific assemblages C or 
D, or a mixture of both. 
 
6.3.2 Giardia in animals in Sweden (Paper III) 
At the onset of this investigation, essentially nothing was known about the distribution 
of different Giardia assemblages in animals in Sweden. The work was conducted over 
a long period, and DNA extraction and PCR-RFLP and sequencing of the β-giardin 
gene were performed continuously on all 114 isolates. Later on, molecular analyses of 
two other markers, the gdh and tpi genes, were performed on all samples. Initially, the 
ssrRNA locus was also investigated, but the information was limited to assemblage 
level, and hence this gene was later used only when no PCR products were obtained 
with the other markers or to verify unusual results. The ssrRNA PCR was useful for 
identifying Giardia species other than G. intestinalis (i.e., G. muris and G. microti), for 
which the success rate was very low when using the other PCR primers. One reason for 
that may have been that the samples from rodents contained very few Giardia parasites, 
and thus a PCR directed towards a multi-copy gene, such as the ssrRNA locus, was 
more sensitive. Another plausible explanation is that the β-giardin, gdh, and tpi primers 
are designed for G. intestinalis and therefore are not optimal for other Giardia species. 
We also found that assemblage D from canine samples was not amplified in the nested 
PCR using the tpi primers described by Sulaiman et al. (2003). Sequencing of the 
product from the primary tpi PCR demonstrated three substitutions at the forward 
primer site and four at the reverse primer site, and, based on this observation, modified 
primers for assemblage D were designed (Table 10). This strategy shows that universal 
primers for G. intestinalis designed using information on sequences from only a few 
isolates might not achieve equal amplification of all assemblages, and it also highlights 
the importance of having a panel of DNA from all various assemblages before a new 
PCR is established. However, according to our experience, this goal is not easily 
achieved, since it took us a considerable amount of time to assemble such a collection. 
 
Assemblage A was detected in a total of 15 animals (nine ruminants, five cats, and one 
dog) and assemblage B in five animals (three monkeys, one rabbit, and one guinea pig). 
Three sheep were infected with both assemblages A and E, and the remaining animals 
harbored the host-specific assemblages C to G or other Giardia species. The zoonotic 
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aspects and other implications of the findings are discussed under the respective 
headings below. 
 
Table 10. Primers for nested tpi PCR (Sulaiman et al., 2003) compared with sequences of 
assemblages A, B, and D  
Assemblage  Acc. no. 
Genbank 
Position from the start of the gene 
   18 24 27 30 528 531 534 537 543 
AI - L02120 C C C T C G C G C 
B - L02116 C C T T C G T G C 
D Swedog105 EU781028 G A T C A T T A T 
D Swedog112 - G A T C A T T A T 
D Swedog119 - G A T C A T T A T 
Primer F 
AL3544 
  C C I
a
 T - - - - - 
Primer R 
AL3545 
  - - - - C G I
a
 G C 
a
I = inosine used at ambiguous positions 
 
6.3.3 Giardia in patients in Sweden (Paper IV) 
As a complement to the study of Giardia assemblages in animals in Sweden, we 
initiated an investigation of patients diagnosed with giardiasis in this country. Stool 
samples from a total of 214 persons were forwarded to SMI. The specimen was sent in 
together with the sediment obtained after formol/ethyl acetate concentration, and thus 
microscopy using the DFA and DAPI techniques could be performed on all samples. 
For all isolates, we attempted PCR amplification of the β-giardin, tpi, and gdh genes, as 
well as tpi PCR with primers specific for assemblages A and B, respectively. RFLP 
analysis was done on all products of the three PCRs. Lastly, sequencing was performed 
on all samples positive in β-giardin PCR and on almost all samples that were 
successfully amplified at the tpi and gdh loci. The success rate was good at all three 
loci, as depicted in Figure 7. In all, 73 patients were infected with assemblage A and 
128 with assemblage B, and six had mixed assemblage A+B infections. However, in 
seven isolates, no amplicons were obtained at any locus; six of these samples contained 
a few Giardia cysts that were empty (i.e., lacked nuclei) according to DAPI staining, 
and the remaining sample had probably been exposed to formalin.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7. Distribution of 207 Giardia isolates successfully amplified at the ß-giardin, tpi, and 
gdh genes. 
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6.3.4 Association of assemblages with symptoms (Paper IV)  
The patient group consisted of 109 females and 105 males. The distribution of 
assemblages in relation to gender was remarkable: among the females, 36 had 
assemblage A and 64 assemblage B; among the males, 37 had assemblage A and 64 
assemblage B. For 181 of the 214 patients (85%) that responded to the questionnaire 
that had been sent to all participants detailed information regarding various symptoms 
was obtained. From the remaining 33 patients partial data concerning symptoms were 
extracted from the mandatory notifications submitted by the clinicians. The merged 
information from these two sources showed that a total of 180 persons had symptoms, 
and 34 were asymptomatic. No association was seen between assemblages and 
symptoms when the whole patient group was examined (p-value 0.58). A more detailed 
analysis was also performed on 145 symptomatic patients (including 51 with 
assemblage A and 87 with assemblage B) that responded to the questionnaire and that 
were not co-infected with other diarrhea-related organisms. The questionnaire included 
items about diarrhea, bowel movements per day, abdominal pain, bloody stools, 
vomiting, flatulence, fever, and weight loss. For all patients, the most common 
symptom was diarrhea (97%), followed by flatulence (78%), and weight loss (73%). 
The only assemblage-symptom correlation found concerned flatulence, which was 
more common in patients with assemblage B (p-value 0.006). Separate analysis of 12 
symptomatic children aged 0–5 years revealed that all six of the children who had 
assemblage B, but none of the other six with assemblage B, reported flatulence. When 
children 0–5 years of age were excluded from the analysis, the correlation between 
assemblage B and flatulence was no longer apparent (p-value 0.16). These findings 
demonstrate that there is a strong correlation between flatulence and infection with 
assemblage B parasites in the age group 0–5 years. At present, we have no explanation 
for why flatulence was not evenly distributed among the children, although it is 
possible that assemblages A and B parasites differ with regard to metabolism. It has 
been shown that assemblage A parasites produce hydrogen gas (Lloyd et al., 2002), 
and, although not yet studied, the level of such gas production might be higher in 
assemblage B. It is also plausible that members of these two assemblages differ with 
respect to how they affect the growth of gas-producing bacteria in the host’s intestine.  
 
According to the questionnaire responses, 10 patients received intravenous fluids while 
they were hospitalized for diarrhea. Seven of these patients were infected with 
assemblage B, one with assemblages A+B, and two with assemblage A. Co-infections 
with Shigella and Campylobacter were observed in one of the assemblage B patients 
and in the patient with mixed assemblage infection. Notably, the two patients with 
assemblage A that received intravenous fluids were both infected in Sweden with a 
unique assemblage A MLG that had previously been found only in our study of 
Giardia genotypes in Swedish animals (see under 6.3.7 Zoonotic transmission).  
 
Another observation was that, of 10 patients who reported joint pain, eight were 
infected with assemblage A and two with assemblage B. None of the patients harbored 
bacteria associated with reactive joint pain, although one patient with assemblage B 
was co-infected with Cryptosporidium. All patients were adults, but the study design 
did not permit us to further explore these findings with regard to location or intensity of 
pain. Reactive joint pain is a well-known symptom following infections with enteric 
bacteria, and it has infrequently been described in patients with giardiasis, mainly 
children (Goobar, 1977; Shaw and Stevens, 1987). An investigation of the health 
sequelae of human cryptosporidiosis revealed that joint pain was more common in 
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Cryptosporidium patients than in healthy control subjects, and it was correlated with 
previous C. hominis infection (Hunter et al., 2004). 
  
6.3.5 Mixed assemblages (Papers II, III, and IV) 
The issue of mixed-assemblage infections has recently received considerable attention, 
and, to further address this question, we subjected the Giardia isolates from Nicaragua 
that we had already sequenced at the β-giardin and gdh loci to additional investigation 
at the tpi locus. This was done using both universal primers and assemblage A- and B-
specific primers (Sulaiman et al., 2003; Geurden et al., 2008; Levecke et al., 2009). 
Table 11 shows that this approach confirmed the two mixed infections that we had 
previously detected at the gdh locus and identified one more patient with assemblage 
A+B infection, resulting in 7% (3/42) mixed assemblage A+B infections in the 
Nicaraguan subjects. These observations nearly agree with the findings reported in 
Paper IV, which were obtained using the same approach and showed that only 3% 
(6/207) of the Swedish patients were infected with both assemblages. In a study in 
Great Britain (Breathnach et al., 2010), another tpi PCR was performed using the 
assemblage-specific primers described by Amar (2002), and, similar to our results, 
mixed infections were found in 3% (6/199) of the patients that were investigated. 
However, these findings differ from those obtained in a Belgian study that used exactly 
the same approach as ours and demonstrated that 32% of the patients had double 
infections (Geurden et al., 2009a). The reason for this discrepancy is not clear, 
considering that the patient populations in the three studies were quite similar and 
represented a mixture of domestic and travel-related infections. The assemblage A- and 
B-specific tpi primers were tested in our laboratory using diluted DNA from cultured 
parasites and a very high sensitivity was found when DNA from assemblage A was 
diluted in a high concentration of assemblage B DNA and vice versa (data not shown). 
Thus it seems that the low rate of mixed-assemblage infections in our studies was not 
related to methodology.  
 
Table 11. Comparison of results of β-giardin, gdh, and tpi PCR performed on 42 Giardia 
isolates from Nicaragua 
 
No. of 
isolates 
Nested 
β-giardin 
Nested 
gdh 
Nested 
tpi 
tpi A+ B 
PCR 
13 A A A A 
1 A A+B A A+B 
1 A A+B B A+B 
1 A A A A+B 
26 B B B B 
 
Lately, considerable attention has also been focused on assemblage swapping (i.e., 
different assemblages indicated by analysis of different loci in the same isolate) (Caccio 
et al., 2008; Almeida et al., 2010). We did not observe such exchange in any of the 
isolates (from humans or animals) that exhibited single-assemblage infections at all 
three loci. Altogether, we have successfully sequenced all three gene loci in 234 human 
isolates and 89 animal isolates, and, apart from the mixed-assemblage infection in nine 
human and eight animal isolates, there was no apparent disagreement between 
assemblages.  
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6.3.6 Intra-isolate sequence divergence (Papers II, III, and IV) 
Sequencing of all three genes revealed a high degree of polymorphism with frequent 
double peaks (overlapping nucleotides) at specific positions in the chromatograms. This 
occurred most often in human assemblage B isolates from both Nicaragua and Sweden, 
although it was also observed in assemblage C, D, and E sequences from animals. 
Double peaks were lacking for almost all sequences from assemblage A, except for a 
few β-giardin sequences at the specific positions distinguishing subtype A2 from 
subtype A3 (Paper IV). A high degree of polymorphism in assemblage B isolates has 
also been noticed in other studies (Robertson et al., 2007; Caccio and Ryan, 2008; Lalle 
et al., 2009) and has been further investigated by cloning (Lasek-Nesselquist et al., 
2008; Hussein et al., 2009; Kosuwin et al., 2010). The complete genome sequencing of 
the assemblage B isolate GS/M (Franzen et al., 2009) showed that the average allelic 
sequence divergence was much higher in this isolate (0.5%) than in the previously 
sequenced assemblage A isolate WB-C6 (< 0.01%) (Morrison et al., 2007). This 
suggests that the greater abundance of mixed positions in assemblage B sequences is 
due to the higher allelic sequence divergence. In addition, the possibility of infections 
with multiple assemblage B strains complicates the picture even more. We observed a 
strong correlation between isolates that generated double chromatogram peaks for all 
three genes and represented infections acquired outside Europe (p-value < 0.001). This 
implies that at least some of the double peaks produced by our assemblage B sequences 
were due to mixed infections, which are presumed to be more common in areas with a 
high Giardia prevalence (Caccio and Ryan, 2008).  
 
Single-cell PCR (unpublished data) 
To further investigate the occurrence of intra-isolate sequence divergence, we 
performed single-cell PCR analyses on trophozoites from the assemblage B isolate 
GS/M (in vitro cultured) and on single cysts from three separate clinical isolates, all 
with double peaks in the original sequences. Two of the isolates (Sweh197 and 
Sweh212) were from patients infected with assemblage B and the third (Sweh207) 
from a patient with mixed assemblage A+B infection. Cysts from the human samples 
were separated using a sucrose gradient. Single trophozoites and cysts were isolated 
through micromanipulation (Fig. 8).  
 
 
Figure 8. Isolation of a single Giardia trophozoite from culture by the micromanipulation 
technique (Photo Johan Ankarklev) 
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In short, to ensure that only single cysts were isolated, selected cysts that had been 
stained in vitro with FITC-conjugated Giardia antibodies were isolated by a 
micromanipulation technique and then transferred to multi-well microscope slides and 
detected visually in a fluorescence microscope. Each well (n = 44) contained only a 
single cyst. DNA from single cysts and trophozoites was liberated using DNAreleasy 
(NIPPON Genetics) and amplified by nested PCR, and this was followed by 
sequencing of the amplicons. The β-giardin and tpi loci were investigated. Sequences 
from nine single GS/M trophozoites showed double peaks in the chromatogram at the 
same positions as the tpi locus in the crude isolate (Table 12). Single cysts from 
assemblage B isolate Sweh197 generated both tpi sequences with double peaks at 
certain positions and sequences without any double peaks (Table 13). Similar results 
(i.e., sequences with and without double peaks) were obtained for single cysts isolated 
from Sweh212 both at the β-giardin and tpi loci (Fig. 9). Single cysts from isolate 
Sweh207 (original isolate with mixed A+B infection) generated 10 assemblage B and 
two assemblage A sequences (identical to subtype A2) at the tpi locus, whereas only 
assemblage B sequences (n = 15) were identified at the β giardin locus. The assemblage 
B sequences from both loci showed a high degree of polymorphism. These results 
indicate that heterogeneous alleles that give rise to polymorphic sequences are present 
within single parasites. The results also showed that single cysts from a patient sample 
with mixed assemblages generated either assemblage B or A sequences. This indicates 
that the sample comprised two distinct isolates and that there was no recombination 
between assemblage A and B at the loci tested (Ankarklev et al., manuscript in 
preparation). 
 
 
Table 12. Nucleotide changes in isolate GS/M at the tpi locus. IUPAC nucleotide codes 
were used indicate multiple nucleotides at polymorphic positions (R=A/G; Y=C/T).  
 
Isolate  Sub-assemblage Position from start of 
gene 
 
   39 45 26 
  BIII G T G 
  BIV A T G 
GS/M Crude isolate BIV R Y R 
GS/M_071 Single trophozoite  R Y R 
GS/M_072 Single trophozoite  R Y R 
GS/M_073 Single trophozoite  R Y R 
GS/M_074 Single trophozoite  R Y R 
GS/M_076 Single trophozoite  R Y R 
GS/M_077 Single trophozoite  R Y R 
GS/M_078 Single trophozoite  R Y R 
GS/M_079 Single trophozoite  R Y R 
GS/M_080 Single trophozoite  R Y R 
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Table 13. Nucleotide changes in isolate Sweh197 at the tpi locus. IUPAC nucleotide 
codes were used indicate multiple nucleotides at polymorphic positions (R=A/G; 
Y=C/T). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9. Four chromatograms from isolate Sweh212 representing the same 11 nucleotide 
region at the β-giardin locus. Sequences from crude isolate (A) and single cysts (B, C, and D). 
 
 
 
Isolate Material Sub-assemblage/ 
subtype 
Position from start of gene 
   39 114 165 280 
  BIII G C C A 
  BIV A C T A 
Sweh197 Crude feces Mixed R Y Y R 
Sweh197_SC200 Single cyst Mixed R Y Y R 
Sweh197_SC084 Single cyst Mixed R C Y R 
Sweh197_SC201 Single cyst Mixed R C Y R 
Sweh197_SC086 Single cyst Mixed R Y C R 
Sweh197_SC098 Single cyst Mixed R Y C R 
Sweh197_SC149 Single cyst Mixed R Y C R 
Sweh197_SC213 Single cyst Mixed R Y C R 
Sweh197_SC196 Single cyst Novel subtype 1 A C C G 
Sweh197_SC197 Single cyst Novel subtype 1 A C C G 
Sweh197_SC212 Single cyst Novel subtype 1 A C C G 
Sweh197_SC207 Single cyst Novel subtype 2 G T C A 
Sweh197_SC215 Single cyst Novel subtype 3 G C T A 
B 
C D 
A 
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6.3.7 Zoonotic transmission (Papers III and IV) 
Most of the animals we studied in Sweden were infected with the host-specific 
assemblages C–G, although assemblages A and B were also found. Figure 10 
presents possible transmissions routes for Giardia in our country, based on our 
investigations of both animal and human isolates. Among 28 canine samples that 
were successfully genotyped, only one contained assemblage A, and the remaining 
harbored the host-specific assemblages C and D. Accordingly, it seems that dogs do 
not play an important role in zoonotic Giardia transmission in Sweden. The opposite 
has been reported from many other countries, where dogs have been pointed out as 
potential sources of human infection because they frequently harbor assemblage A 
(Claerebout et al., 2009; Sprong et al., 2009). The canine samples from Nicaragua 
that we analyzed also displayed assemblages C and D, but, since only eight of the 100 
dogs we investigated were positive for Giardia, it is impossible to draw any 
conclusions. In our samples from Sweden, we found assemblage A mainly in sheep 
and wildlife (moose and deer), but also in some cats. Phylogenic trees and MLG 
analysis showed that none of these animals harbored sub-assemblage AII, which was 
the most common sub-assemblage identified in the human assemblage A isolates 
(Fig. 11). Unexpectedly, in October 2008, isolates from three patients were observed 
to exhibit the same novel assemblage A RFLP pattern (unpublished data) at the β-
giardin gene that had previously been demonstrated for most animal isolates with 
assemblage A. Later, we found that these three patients had MLGs identical to those 
identified in some ruminants and cats. Two of these patients had not been in contact 
with any particular animal, but the third was a moose and deer hunter who had taken 
part in a hunting expedition shortly before he became symptomatic. All three patients 
reported that they had not traveled abroad prior to infection, and, as already 
mentioned, two of them were hospitalized and received intravenous fluids.  
 
Few of the animals we studied in Sweden were infected with assemblage B, and thus 
comparison of human and animal isolates was possible in only a few cases. One 
rabbit (Rabbit176) had diarrhea and its owner had previously been treated for 
giardiasis, and, considering all three markers this animal had subtypes that had also 
been detected earlier analyses of human Giardia isolates, although the sequence 
combination (MLG) observed was not exactly the same as that seen in any of our 
patients infected with assemblage B (Fig. 10). Unfortunately, no parasites from the 
rabbit owner were available for analysis. Rabbits and guinea pigs are often kept as 
pets, but remarkably few Giardia studies have included these animals (Giangaspero et 
al., 2007). 
 
The above-mentioned examples certainly pinpoint the difficulties involved in 
connecting human and animal Giardia cases when zoonotic transmission is 
suspected. Nevertheless, our findings strongly suggest that zoonotic transmission of 
Giardia can occur in Sweden, although such dissemination is not very common.  
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6.3.8 Source tracing (Paper IV) 
 
No larger outbreaks of giardiasis occurred in the Stockholm area during the study 
period, but 18 small family clusters were identified, each of which involved two to five 
individuals. In two of these clusters, the family members harbored either assemblage A 
or B, and thus it was quite obvious that they were infected with parasites from different 
sources. In six other clusters infected exclusively with assemblage A and whose MLGs 
were successfully determined, the value of genotyping was limited, because these A 
MLGs were common in our other patients as well. In contrast, multilocus genotyping of 
assemblage B isolates appeared to be a reliable tool for source tracing in some 
instances. This was indicated by the observation that in five family clusters the 
members shared identical MLGs. On the other hand, in several of the clusters in which 
assemblage B isolates were identified, the frequent occurrence of overlapping 
nucleotides in the sequences hampered the allocation of the isolates to a particular 
MLG. Clearly, investigation of sequences obtained from crude feces isolates cannot 
reveal whether this polymorphism was due to infections with mixed subtypes or allelic 
sequence divergence, or a combination of both. A similar observation was made during 
a large waterborne outbreak of giardiasis in Bergen, Norway, where genotyping of 
assemblage B isolates from the affected patients showed substantial variability 
(Robertson et al., 2006). So the paradox is that either there is insufficient genetic 
variation in the loci investigated (assemblage A) or the polymorphism is too extensive 
(assemblage B) to allow reliable source tracing. 
 
6.3.9 Treatment and treatment failure (Paper IV)  
The Swedish Society for Communicable Disease Prevention and Control stipulates that 
all cases of giardiasis should be treated, regardless of symptoms. Information 
concerning treatment was obtained for the majority of the patients in our investigaiton, 
but follow-up after treatment was outside the scope of the present research. 
Notwithstanding, during the study period we noted that 10 patients had delivered a 
second stool sample after being treated with metronidazole or tinidazole, and we 
analyzed those samples by use of the same molecular tools as we had applied to the 
other samples. The findings showed that assemblage B was more common among those 
10 patients and also indicated that several of those individuals were infected in India, 
although the genotyping results were inconclusive due to the extensive polymorphism 
in the assemblage B isolates. Reduced sensitivity to the drugs commonly used to treat 
Giardia is recognized in the literature and has been thoroughly assessed after an 
outbreak situation (Morch et al., 2008). Despite that, little is known about the 
assemblages involved in sporadic cases, and hence further research is needed in that 
context (Robertson et al., 2010). 
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7  PAST, PRESENT AND FUTURE WORK 
 
Prior to the studies underlying this thesis, no investigations had been conducted to 
examine the distribution of E. histolytica and E. dispar in Sweden, and thus over-treat-
ment due to incomplete diagnostic procedures was probably the rule. Over the years, it 
has become increasingly evident that making a correct laboratory diagnosis is highly 
important, and, ideally, this should be achieved for all samples containing 
E. histolytica/E. dispar parasites. Therefore, it is important to ensure that future work 
on Entamoeba in Sweden focuses on implementation of methods for species differen-
tiation at local parasitology laboratories, so that all patients can receive a correct diag-
nosis together with the initial report based on microscopic findings.  
 
The present work has also generated a large set of DNA samples from different amoeba 
parasites, part of which have already been used to study the genetic diversity of 
Entamoeba (Stensvold et al., manuscript) and the occurrence of E. moskhowskii in our 
part of the world (Stensvold et al., 2010b). Moreover, the investigation of Entamoeba 
in humans has drawn interest in the genetic diversity of amoebas found in animals, a 
hitherto rather unexplored subject (Stensvold et al., 2010a). 
 
Through our analyses of Giardia isolates from humans and animals in Sweden and 
Nicaragua, we have accumulated basic knowledge concerning assemblages and geno-
types in these populations. We have also compiled a unique collection of well-defined 
Giardia DNAs that have been investigated at several loci and represent assemblages 
A–G, as well as a large number of subtypes. A selection of these DNAs has recently 
been used to develop a rapid technique for genotyping based on real-time PCR with 
subsequent sequencing (Wahab et al. accepted manuscript). In addition, more than 100 
unique Giardia sequences have been submitted to the Genbank database. Together, 
these efforts have created a framework for further Giardia research in Sweden, 
especially regarding zoonotic transmission, connection between genotype and symp-
toms, and identification of virulence and drug-resistance genes. 
 
As a spin-off of the research reported in this thesis, we established in vitro cultures of 
two G. intestinalis assemblage AII isolates representing subtypes A2 and A3 in β-
giardin. The whole genomes of these two isolates have been sequenced using the 454 
technique, and the data thus obtained have revealed differences in chromosomal 
patterns, sensitivity to drugs, growth rate, and encystation efficiency compared to the 
standard assemblage AI isolate WB (Ankarklev et al., manuscript in preparation). 
Hopefully, one outcome of these data will be the identification of a gene locus that is 
more efficient for source tracing of Giardia assemblage A than those that are presently 
used. Another consequence of the current work has been the single-cell PCR (per-
formed on trophozoites and cysts, and described in part here), which has proved what 
has long been suspected but not previously seen, namely, that mixed alleles occur in 
single Giardia parasites (Ankarklev et al., manuscript in preparation)  
 
Microscopy has been the basic technique for detection of parasites in this research, and 
molecular methods have constituted the tool for further identification. The current trend 
in diagnostic parasitology is heading towards newer strategies, either immunology- or 
molecular-based. Hopefully, the art of microscopy will not be forgotten, but instead 
employed in combination with other techniques.  
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